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ABSTRACT 
 
Quinones are the metabolites of a class of chemicals known as polycyclic 
aromatic hydrocarbons.  These chemicals have been found to be toxic in the environment, 
especially when interacting with certain proteins.  In this study, we investigated the 
modification of Lysozyme and Ribonuclease A by a series of benzoquinones as well as 
few naphthoquinones.  Fluorescence spectroscopy was used to measure the degree of 
modification of Lysozyme and Ribonuclease A when incubated with quinones at 
differing concentrations and for various times.  All reactions, unless noted, were carried 
out in a phosphate buffer (pH=7.0) at 37°C to mimic physiological conditions.  The 
fluorescence intensity of modified protein was shown to be less than that of unmodified 
protein, and effects of quinone substituents were examined.  UV-VIS spectroscopy was 
also utilized to monitor adduct formation and other protein modifications.  This study 
adds to our understanding of the effects of quinones on biological systems. 
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CHAPTER 1 
INTRODUCTION 
  
 2 
1.1 A Brief Description of Quinones 
 
Quinones are six-membered carbon rings with two carbon-oxygen double bonds 
and two carbon-carbon double bonds within the ring itself.  Examples of quinones used in 
this research are shown below in Figure 1.1. 
 
 
 
 
 
Figure 1.1 Quinones used in this research (1,4-benzoquinone (PBQ), 2-chloro-1,4-
benzoquinone (CBQ), 2-methyl-1,4-benzoquinone (MBQ)) 
 
Quinones may originate from polycyclic aromatic hydrocarbons (PAHs) and 
exhibit toxic behavior in many ways [Snyder et al., 1989; Snyder & Hedli, 1996; Huff et 
al., 1989; Cornwell et al., 2003].  For example, quinones can exhibit their toxicity 
through redox cycling, adduct formation, and/or inducing enzyme polymerization [Kim et 
al., 2012; Kim et al., 2015].  Redox cycling is initiated by quinone reduction by a 
reductase, which then is followed by oxidation by molecular oxygen.  Adduct formation 
is the process of quinone attacking and attaching covalently to a protein.  Quinones can 
also act as a link between proteins leading to protein oligomerization and polymerization.  
In the body, quinones are highly reactive and can cause damage to healthy cells through 
DNA modification, lipid modification, and, the focus of this study, protein modification 
 3 
[Kim et al. 2012; Vaughn, 2013; Bolton et al., 2000; Batra et al., 2006; Kim, 2013; 
Snyder et al., 1989]. 
Quinones used in this research are listed as follows: 1,4-benzoquinone (PBQ), 2-
methyl-1,4-benzoquinone (MBQ), 2-chloro-1,4-benzoquinone (CBQ), tetrachloro-1,4-
benzoquinone (TCBQ), phenyl-1,4-benzoquinone (PhBQ), 2-hydroxy-1,4-
naphthoquinone (HNQ), 1,2-naphthoquinone (ONQ), and 1,4-naphthoquinone (PNQ).  
These quinones were selected due to the different electronic effects and various 
modifications they can produce when incubated with protein.  For example, some 
quinone substituents exhibited greater electron donating effects versus electron 
withdrawing effects.  This difference led to varying degrees of protein modification with 
electron withdrawing effects causing the most modification.  Other differences between 
quinones were differences in consistency, color, and solubility.  All quinones mentioned 
above were incubated with Lysozyme while only HNQ was incubated with Ribonuclease 
A.   
 
1.2 Background Information on Proteins and Methods Used 
 
Polycyclic aromatic hydrocarbons and their metabolites can specifically lead to 
protein aggregation.  Studying PAH metabolites is interesting due to recent findings of 
the observed protein modifications to Ribonuclease A induced by PBQ as presented in 
Figure 1.2 [Kim et al., 2012; Kim et al., 2015]. 
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Figure 1.2 Fluorescence spectra of RNase A (0.050 mM) and RNase A (0.050 mM) 
modified by PBQ (0.050, 0.25, 0.50, or 1.50 mM) [Kim et al., 2012]. 
 
When proteins begin to aggregate, the result can disrupt encoding pathways 
leading to improper function of the cells.  Protein aggregation occurs naturally as one 
gets older, and sometimes is the cause of Alzheimer’s, Parkinson’s, or Huntington’s 
disease [Bemporad et al., 2006; Chiti & Dobson, 2006; Chiti & Dobson, 2009; Dobson, 
2003; Ramirez-Alvarado, 2008; Gregersen et al., 2006].  It can easily be understood how 
mature protein aggregation can be toxic; however, recent research has shown that 
immature protein aggregations are much more toxic [Zhu et al., 2000; Nilsberth et al., 
2001].  In this research, the interaction between a variety of quinones and two well-
studied proteins, Lysozyme and Ribonuclease A, is investigated and quantified by use of 
fluorescence and UV-VIS spectroscopy. 
Lysozyme is a model protein in biochemical research due to its relatively small 
size and ability to form crystals which are easy to manipulate [Swaminathan et al., 2011].  
The function of Lysozyme is to hydrolyze glycosidic bonds between N-acetylmuramic 
acid and N-acetylglucosamine in Gram-positive bacteria, essentially acting as an 
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antibacterial agent [Willey et al., 2011].  Lysozyme was chosen for these studies due to 
its similar characteristics to proteins that have been found linked to neurodegenerative 
diseases.  Specifically, Lysozyme is an amyloidogenic protein which makes it useful for 
comparison and understanding of such proteins that can generate plaques which cause 
bodily harm.  In addition, Lysozyme exhibits good fluorescence behavior made possible 
by tyrosine and tryptophan residues which make up the protein. 
 Ribonuclease A is a model protein in biochemical research similar in size and 
crystal formation to Lysozyme.  The function of Ribonuclease A is to degrade RNA 
strands into smaller parts.  With a high affinity for single strand RNA, Ribonuclease A 
can exhibit its nuclease behavior both as an endonuclease and exonuclease [Voet et al., 
2012].  Since Ribonuclease A is extremely common in our bodies and in the 
environment, it is an excellent protein to use in measuring the modification by other 
potentially harmful agents in the environment.  In comparison with Lysozyme, 
Ribonuclease A is a non-amyloidogenic protein and therefore does not produce harmful 
plaques upon alteration of the protein structure.  Though Ribonuclease A exhibits less 
fluorescence behavior than Lysozyme due to the absence of tryptophan, excess tyrosine 
residues contribute to the overall fluorescence behavior of the molecule.   
Fluorescence spectroscopy is an analytical spectroscopic technique used to 
measure the fluorescence behavior of certain molecules at a highly sensitive level.  Upon 
radiation with incident light, molecules absorb energy when their electrons are excited to 
higher energy levels and release energy when their electrons return to a more stable state.  
This process is known as fluorescence and can be used to identify molecules in addition 
to measuring changes molecules undergo [Skoog et al., 2007].  In this research, the 
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fluorescence behavior of proteins was measured to gain insight on the potential degree of 
modification caused by exposure to quinone molecules.  The fluorescence of pure protein 
was compared with the fluorescence of altered protein as result of quinone molecules 
performing modification.  Since both proteins used in this study contained amino acid 
residues with high quantum yields (tryptophan and tyrosine), the fluorescence behavior of 
the protein was dominated by these amino acids.  It is believed any alteration to the 
fluorescence behavior of protein upon incubation with quinone is result of some 
structural change to the protein or an addition of quinone to the protein.  This 
modification of protein affects the amino acid residues responsible for fluorescence, and 
ultimately cause a change in the fluorescence behavior of the protein. 
UV-VIS spectroscopy is an analytical spectroscopic technique used to measure 
the absorbance of certain molecules in the UV-VIS region of the electromagnetic 
spectrum.  Upon radiation with incident light, molecules absorb energy as their electrons 
are excited to higher energy levels and it is this absorbance that is measured with UV-
VIS spectroscopy [Skoog et al., 2007].  Similar to fluorescence, certain amino acid 
residues, such as tryptophan and tyrosine, dominate in regard to the ability of absorbing 
energy.  Due to UV-VIS spectroscopy being a technique of measuring absorbance, any 
addition of molecules that absorb in the UV-VIS range will affect the overall absorbance 
of the original molecule before addition of other molecules.  It is believed that the 
addition of quinone to the proteins used in this study increases the absorbance of the 
modified protein because of covalently attached quinone molecules which, by 
themselves, absorb highly in the UV-VIS range. 
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1.3 Prior Studies in Our Lab 
 
Much research has been performed at UTC over the past several years regarding 
Lysozyme, Ribonuclease A, and quinones.  The results of these studies have paved the 
way for the understanding of the results presented in Chapters 2 and 3.  Previous research 
has centered around the modification of protein specifically through protein crosslinking 
which results in protein oligomerization.  This modification has been verified mainly 
through use of SDS-PAGE with fluorescence and UV-VIS spectroscopy as supporting 
analytical techniques.  Several prior studies have utilized SDS-PAGE gels which support 
the results collected through this study.  In this chapter, results from previous studies will 
be presented and discussed. 
 
1.3.1 Modifications of ribonuclease A induced by p-benzoquinone 
In these studies carried out by Kim et al., Ribonuclease A modifications were 
investigated upon exposure to PBQ at various concentrations [Kim et al., 2012].  
Ribonuclease A was fixed at a concentration of 0.050 mM with PBQ used at 0.050, 0.25, 
0.50, or 1.50 mM.  Fluorescence spectroscopy along with UV-VIS spectroscopy was 
utilized to examine the spectrophotometric characteristics of Ribonuclease A after 
exposure to PBQ in addition to unmodified Ribonuclease A.  SDS-PAGE was also 
utilized to visualize polymeric aggregates formed by the various reactions.  All studies 
were performed using a phosphate buffer (50 mM) at pH=7.0 and 37°C. 
 The major findings of these studies are straight forward, PBQ does elicit 
modification of Ribonuclease A by forming both Ribonuclease A adducts and polymeric 
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aggregates.  Figure 1.3 shows corresponding graphs of fluorescence and UV-VIS spectra 
of Ribonuclease A incubated with PBQ [Kim et al., 2012]. 
 
Figure 1.3 (A) Fluorescence and (B) UV-VIS spectra of RNase A (0.050 mM) and 
modified RNase A by PBQ (0.050, 0.25, 0.50, or 1.5 mM) for 24 h at 
37°C [Kim et al., 2012]. 
 
The fluorescence behavior of modified Ribonuclease A is found to be less than 
unmodified Ribonuclease A indicating PBQ does elicit detectable modifications of 
Ribonuclease A.  In addition, UV-VIS studies indicate PBQ formed covalent bonds to the 
modified Ribonuclease A supporting adduct formation induced by PBQ.  As seen in 
Figure 1.4, SDS-PAGE results show PBQ is efficient in producing oligomers over time 
by observing the results of previously performed reactions involving PBQ and 
Ribonuclease A [Kim et al., 2012]. 
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Figure 1.4 Concentration and time-dependent modification of RNase A upon 
exposure to PBQ at 0.50 mM and 5.0 mM in phosphate buffer (pH=7.0, 50 
mM) at 37°C [Kim et al., 2012]. 
 
Overall, these results show PBQ can induce formation of both Ribonuclease A 
adducts and aggregates. 
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1.3.2 A comparison study on ribonuclease A modifications  
induced by substituted p-benzoquinones 
In these studies carried out by Kim et al., Ribonuclease A modifications were 
investigated upon exposure to PBQ, MBQ, or CBQ [Kim et al., 2015].  Fluorescence 
spectroscopy along with UV-VIS spectroscopy was utilized to examine the 
spectrophotometric characteristics of Ribonuclease A after exposure to PBQ, MBQ, 
CBQ, and unmodified Ribonuclease A.  SDS-PAGE was also utilized to visualize 
polymeric aggregates formed by the various reactions using each quinone.  In SDS-
PAGE experiments, Ribonuclease A was fixed at a concentration of 0.145 mM with each 
quinone used at 1.0 mM.  All studies were performed using a phosphate buffer (50 mM) 
at pH=7.0 and 37°C. 
 As with previous studies, each quinone elicited modification of Ribonuclease A 
by forming polymeric aggregates and adducts.  From these studies, it was found each 
quinone caused varying degrees of modification when incubated for the same amount of 
time.  As seen in Figure 1.5, the fluorescence behavior of modified Ribonuclease A is 
found to be less than unmodified Ribonuclease A indicating that all quinones elicit 
modification of Ribonuclease A [Kim et al., 2015].  In addition, UV-VIS studies indicate 
all quinones covalently bond to Ribonuclease A supporting the previously described 
pathway of modification through adduct formation.  As seen in Figure 1.6, SDS-PAGE 
results show all quinones modify Ribonuclease A through oligomerization [Kim et al., 
2015].  CBQ was found to cause the quickest and most pronounced degree of 
modification and MBQ was found to cause the least degree of modification. 
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 Overall, these studies show an order of increasing reactivity towards 
Ribonuclease A beginning with MBQ causing the least modification, PBQ causing an 
intermediate level of modification, and CBQ causing the greatest modification. 
 
 
 
Figure 1.5 (A) Fluorescence and (B) UV-VIS spectra of RNase A (0.050 mM) and 
modified RNase A by PBQ, CBQ, or MBQ (0.50 mM) for 24 h at 37°C 
[Kim et al., 2015].   
 
 
 
 
Figure 1.6 Time-dependent modification of RNase A (0.145 mM) treated with MBQ, 
PBQ, or CBQ (1.0 mM) for 1, 2, 3, 4 ,5 h at 37°C in phosphate buffer 
(pH=7.0, 50 mM).  MM, protein standard molecular marker; U, RNase A; 
(A) RNase A + MBQ; (B) RNase A + PBQ; (C) RNase A + CBQ [Kim et 
al., 2015].   
  
 12 
1.3.3 Modifications of Lysozyme by Substituted Benzoquinones 
 In these studies carried out by Greve & Kim presented in a Departmental Honors 
Thesis at UTC, Lysozyme modifications were investigated upon exposure to PBQ, CBQ, 
or MBQ [Greve & Kim, 2015].  SDS-PAGE was used to verify any modification of 
Lysozyme through induction of polymeric aggregation by PBQ, CBQ, or MBQ.  
Lysozyme was fixed at a concentration of 0.10 mM with quinones used at 0.10, 0.50, 1.0, 
and 3.0 mM.  All studies were performed using a phosphate buffer (50 mM) at pH=7.0 
and 37°C.   
 Due to the similarities of Lysozyme to Ribonuclease A, similar results were 
achieved regarding protein modification by PBQ, CBQ, and MBQ.  Specifically, the 
amount of polymeric aggregate formation formed by CBQ opposed to PBQ and MBQ.  
In addition, aggregate formation was found to be decreasing with respect to decreasing 
concentration of quinone.  This result was true for all quinones with the only difference 
being the degree of oligomerization each quinone was responsible for inducing.  Figures 
1.7 through 1.10 show PBQ elicits intermediate modification of Lysozyme through 
protein oligomerization leading to polymeric aggregation [Greve & Kim, 2015].  As seen 
in Figures 1.11 through 1.14, CBQ, having electron withdrawing properties, favors 
interaction with nucleophilic amino acid residues from Lysozyme and induces protein 
oligomerization [Greve & Kim, 2015].  However, as seen in Figures 1.15 through 1.18, 
the studies performed with MBQ showed little polymeric aggregation compared to PBQ 
and MBQ and suggest MBQ, having electron donating properties, does not produce 
significant modifications to Lysozyme [Greve & Kim, 2015].  
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 Overall, SDS-PAGE studies show dimer, trimer, and polymeric aggregate 
formation across all reactions involving quinones and Lysozyme.  Concentration of 
quinone plays an important role in determining the degree of protein crosslinking along 
with the length of incubation.  Similar to previous studies performed by Kim et al., CBQ 
elicits the greatest modification of Lysozyme, PBQ elicits intermediate modification of 
Lysozyme, and MBQ elicits the least modification of Lysozyme [Kim et al., 2015]. 
 
 
 
Figure 1.7 Time-dependent modification of Lyz (0.10 mM) treated with PBQ (3.0 
mM) for 10, 30, 60, 120, 180, 240, and 300 min at 37°C in phosphate 
buffer (pH=7.0, 50 mM).  MM, molecular marker; L1, Lyz (0.10 mM); 
L2-L8, Lyz + PBQ (3.0 mM) 10-300 min, L9, Lyz + PBQ (3.0 mM) 24 h 
[Greve & Kim, 2015].   
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Figure 1.8 Time-dependent modification of Lyz (0.10 mM) treated with PBQ (1.0 
mM) for 10, 30, 60, 120, 180, 240, and 300 min at 37°C in phosphate 
buffer (pH=7.0, 50 mM).  MM, molecular marker; L1, Lyz (0.10 mM); 
L2-L8, Lyz + PBQ (1.0 mM) 10-300 min, L9, Lyz + PBQ (1.0 mM) 24 h 
[Greve & Kim, 2015].   
 
 
 
 
Figure 1.9 Time-dependent modification of Lyz (0.10 mM) treated with PBQ (0.50 
mM) for 10, 30, 60, 120, 180, 240, and 300 min at 37°C in phosphate 
buffer (pH=7.0, 50 mM).  MM, molecular marker; L1, Lyz (0.10 mM); 
L2-L8, Lyz + PBQ (0.50 mM) 10-300 min, L9, Lyz + PBQ (0.50 mM) 24 
h [Greve & Kim, 2015].   
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Figure 1.10 Time-dependent modification of Lyz (0.10 mM) treated with PBQ (0.10 
mM) for 10, 30, 60, 120, 180, 240, and 300 min at 37°C in phosphate 
buffer (pH=7.0, 50 mM).  MM, molecular marker; L1, Lyz (0.10 mM); 
L2-L8, Lyz + PBQ (0.10 mM) 10-300 min, L9, Lyz + PBQ (0.10 mM) 24 
h [Greve & Kim, 2015].   
 
 
 
 
Figure 1.11 Time-dependent modification of Lyz (0.10 mM) treated with CBQ (3.0 
mM) for 10, 30, 60, 120, 180, 240, and 300 min at 37°C in phosphate 
buffer (pH=7.0, 50 mM).  MM, molecular marker; L1, Lyz (0.10 mM); 
L2-L8, Lyz + CBQ (3.0 mM) 10-300 min, L9, Lyz + CBQ (3.0 mM) 24 h 
[Greve & Kim, 2015].   
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Figure 1.12 Time-dependent modification of Lyz (0.10 mM) treated with CBQ (1.0 
mM) for 10, 30, 60, 120, 180, 240, and 300 min at 37°C in phosphate 
buffer (pH=7.0, 50 mM).  MM, molecular marker; L1, Lyz (0.10 mM); 
L2-L8, Lyz + CBQ (1.0 mM) 10-300 min, L9, Lyz + CBQ (1.0 mM) 24 h 
[Greve & Kim, 2015].   
 
 
 
 
Figure 1.13 Time-dependent modification of Lyz (0.10 mM) treated with CBQ (0.50 
mM) for 10, 30, 60, 120, 180, 240, and 300 min at 37°C in phosphate 
buffer (pH=7.0, 50 mM).  MM, molecular marker; L1, Lyz (0.10 mM); 
L2-L8, Lyz + CBQ (0.50 mM) 10-300 min, L9, Lyz + CBQ (0.50 mM) 24 
h [Greve & Kim, 2015].   
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Figure 1.14 Time-dependent modification of Lyz (0.10 mM) treated with CBQ (0.10 
mM) for 10, 30, 60, 120, 180, 240, and 300 min at 37°C in phosphate 
buffer (pH=7.0, 50 mM).  MM, molecular marker; L1, Lyz (0.10 mM); 
L2-L8, Lyz + CBQ (0.10 mM) 10-300 min, L9, Lyz + CBQ (0.10 mM) 24 
h [Greve & Kim, 2015].   
 
 
 
 
Figure 1.15 Time-dependent modification of Lyz (0.10 mM) treated with MBQ (3.0 
mM) for 10, 30, 60, 120, 180, 240, and 300 min at 37°C in phosphate 
buffer (pH=7.0, 50 mM).  MM, molecular marker; L1, Lyz (0.10 mM); 
L2-L8, Lyz + MBQ (3.0 mM) 10-300 min, L9, Lyz + MBQ (3.0 mM) 24 
h [Greve & Kim, 2015].   
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Figure 1.16 Time-dependent modification of Lyz (0.10 mM) treated with MBQ (1.0 
mM) for 10, 30, 60, 120, 180, 240, and 300 min at 37°C in phosphate 
buffer (pH=7.0, 50 mM).  MM, molecular marker; L1, Lyz (0.10 mM); 
L2-L8, Lyz + MBQ (1.0 mM) 10-300 min, L9, Lyz + MBQ (1.0 mM) 24 
h [Greve & Kim, 2015].   
 
 
 
 
Figure 1.17 Time-dependent modification of Lyz (0.10 mM) treated with MBQ (0.50 
mM) for 10, 30, 60, 120, 180, 240, and 300 min at 37°C in phosphate 
buffer (pH=7.0, 50 mM).  MM, molecular marker; L1, Lyz (0.10 mM); 
L2-L8, Lyz + MBQ (0.50 mM) 10-300 min, L9, Lyz + MBQ (0.50 mM) 
24 h [Greve & Kim, 2015].   
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Figure 1.18 Time-dependent modification of Lyz (0.10 mM) treated with MBQ (0.10 
mM) for 10, 30, 60, 120, 180, 240, and 300 min at 37°C in phosphate 
buffer (pH=7.0, 50 mM).  MM, molecular marker; L1, Lyz (0.10 mM); 
L2-L8, Lyz + MBQ (0.10 mM) 10-300 min, L9, Lyz + MBQ (0.10 mM) 
24 h [Greve & Kim, 2015].   
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1.3.4 Ribonuclease A Modification Induced by 1,2-Naphthoquinone and  
2-Hydroxy-1,4-Naphthoquinone 
 
In these studies carried out by Smith & Kim presented in a Departmental Honors 
Thesis at UTC, Ribonuclease A modifications were investigated upon exposure to ONQ 
and HNQ [Smith & Kim, 2015].  Ribonuclease A was fixed at a concentration of 0.10 
mM with naphthoquinones used at 5.0 mM.  SDS-PAGE was primarily used to examine 
the modification of Ribonuclease A through protein oligomerization induced by ONQ or 
HNQ.  Reactions with Ribonuclease A were performed at pH=7.0 and 37°C to mimic 
physiological conditions.  In addition, to fully understand the effects of each 
naphthoquinone on Ribonuclease A, the incubation conditions of Ribonuclease A were 
varied regarding pH.  Considering HNQ, specifically the ionizable hydroxyl group, 
changes in the pH of the incubation condition would supposedly alter the functionality of 
both Ribonuclease A and HNQ. 
 As seen in Figure 1.19, SDS-PAGE results show ONQ to elicit greater activity 
towards Ribonuclease A resulting in protein oligomerization [Smith & Kim, 2015].  As 
seen in Figures 1.20 and 1.21, HNQ, regardless of pH change, was not found to cause 
protein oligomerization and was believed to carry out its protein modifying capabilities 
through other mechanisms [Smith & Kim, 2015].  It is these mechanisms that are 
investigated and discussed more in Chapter 3. 
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Figure 1.19 Time-dependent modification of RNase A (0.10 mM) treated with ONQ 
(5.0 mM) for 10 min, 30 min, 1, 2, 3, and 24 h at 37°C in phosphate buffer 
(pH=7.0, 50 mM).  L1, RNase A (0.10 mM), L2-L7, RNase A + ONQ (5.0 
mM) 30 min-24 h, L8, molecular marker [Smith & Kim, 2015].   
 
 
 
Figure 1.20 Time-dependent modification of RNase A (0.10 mM) treated with HNQ 
(5.0 mM) for 10 min, 30 min, 1, 2, 3, and 24 h at 37°C in phosphate buffer 
(pH=7.0, 50 mM).  L1, RNase A (0.10 mM), L2-L7, RNase A + HNQ (5.0 
mM) 30 min-24 h, L8, molecular marker [Smith & Kim, 2015].   
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Figure 1.21 Time-dependent modification of RNase A (0.10 mM) treated with HNQ 
(5.0 mM) for 10 min, 30 min, 1, 2, 3, and 24 h at 37°C in phosphate buffer 
(pH=4.8, 50 mM).  L1, RNase A (0.10 mM), L2-L7, RNase A + HNQ (5.0 
mM) 30 min-24 h, L8, molecular marker [Smith & Kim, 2015].   
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CHAPTER 2 
STUDIES OF LYSOZYME MODIFICATIONS INDUCED BY QUINONES 
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2.1 Introduction 
 
In previous studies performed by Greve & Kim, certain quinones have been found 
to induce modification of Lysozyme [Greve & Kim, 2015].  So far, PBQ, MBQ, and 
CBQ have all been found to elicit modification of Lysozyme through protein 
crosslinking, which yields protein oligomerization, and adduct formation.  This current 
study seeks to add to previous studies regarding the quinones mentioned above, as well as 
test several others on their modifying capabilities towards Lysozyme.  Additional 
quinones include: TCBQ, PhBQ, HNQ, ONQ, and PNQ.  In addition, certain parameters 
such as pH and temperature are altered to investigate their effects on the modification of 
Lysozyme incubated with PBQ.  Fluorescence and UV-VIS spectroscopy were used to 
examine the modifications of Lysozyme induced by these quinones. 
 
2.2 Methodology 
 
All chemicals were purchased from Sigma Aldrich, Fisher, Acros Organics, or 
MP Biomedicals and were of reagent grade.  The protein of interest, Lysozyme (from 
hen egg white), was purchased from MP Biomedicals and kept frozen for preservation 
until ready for use.  All water used in this study was deionized (DI) water purified by a 
Millipore system (Milli-Q).  All solutions were made in lab and kept sealed or covered 
until ready for use.  All reactions were performed in a similar manner following the 
devised experimental protocol to keep error at a minimum.  Each study was performed 
over a three-day period consisting of (1) preparing and starting the reaction, (2) 
 25 
performing dialysis of the incubated solution, and (3) finishing the reaction.  Quartz 
cuvettes, purchased from Starna Cells, Inc., were re-used after being thoroughly cleaned 
with Starna Cells, Inc. cuvette cleaner and allowed to dry.  At times, when higher 
concentration reactions were performed, a film-like residue would build up on the inside 
of the reaction cuvette.  This was cleaned by filling to the brim with concentrated nitric 
acid and allowed to soak overnight.  The next day, the normal cleaning procedure with 
cuvette cleaner was performed to ensure a thorough cleaning of the cuvette.  
Physiological conditions (pH=7.0, 37°C) were modeled for all reactions except for 
studies in which the pH or temperature was varied.  At all times, proper laboratory 
protocol was followed and the laboratory was kept in clean and functional condition. 
 
2.2.1 Buffer Solution 
A phosphate buffer (50 mM), comprised of a mixture of monobasic monosodium 
phosphate crystal (NaH2PO4·H2O) and dibasic disodium phosphate anhydrous 
(Na2HPO4), was prepared and used for all reactions in this study.  Most reactions were 
performed at pH=7.0 and 37°C to mimic physiological conditions.  However, some 
reactions were performed at a different pH or temperature to study the effect of changing 
these factors.  The phosphate buffer solution was used in every 3 mL reaction cuvette as 
well as in 1 L beakers when performing dialysis.  Solutions of NaH2PO4·H2O (50 mM) 
and Na2HPO4 (50mM) were combined in ratios to produce a solution at a pH pre-
determined by the Henderson-Hasselbalch equation (Eq. 2.1). 
𝑝𝐻 = 𝑝𝐾𝑎 + 𝑙𝑜𝑔
[𝑏𝑎𝑠𝑒]
[𝑎𝑐𝑖𝑑]
  (Eq. 2.1) 
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A phosphate buffer solution was chosen primarily because of the multiple 
dissociation constants of phosphoric acid.  Since the second deprotonation of phosphoric 
acid has a pKa around 7.2, an equilibrium between NaH2PO4·H2O and Na2HPO4 creates 
an effective buffering range around pH=7.0.  Due to the physiological approach of the 
study, the use of phosphates in the buffer solution keeps the study in line with biological 
systems.   
To perform a reaction, 4 L of buffer was made fresh the day before each reaction.  
14.19 g of Na2HPO4 (50mM) was weighed and carefully poured in a 2 L volumetric flask 
followed by dilution to the line with deionized water.  Following the same procedure, 
13.79 g of NaH2PO4·H2O (50 mM) was weighed and carefully poured in a similar 2 L 
volumetric flask, again diluting to the line with deionized water.  To have enough 
Na2HPO4 (50mM) for pH=7.0, an additional 0.500 L of Na2HPO4 (50mM) was made by 
weighing 3.55 g of Na2HPO4 (50mM) and following the same dilution and mixing 
protocol mentioned above.  These flasks were subjected to stirring by mechanical means 
for roughly 30 min.  Once fully dissolved, the two solutions of acid and base were 
combined in pre-determined ratios, 1 L at a time, to produce the desired pH of the buffer. 
For example, for a buffer solution at pH=7.0, 557 mL of Na2HPO4 (50 mM) was 
combined with 443 mL of NaH2PO4·H2O (50 mM), adequately mixed, and transferred 
into a 4 L plastic jug.  This process was repeated three additional times to produce 4 L of 
buffer solution.  The final pH of solution was checked using a Fisher AB15 Accumet pH 
meter equipped with an AccuTupH probe.  After calibration with stock solutions at 
pH=4.00 and pH=10.01, if the pH of the buffer solution was within ± 0.05 units of the 
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desired pH, the solution was acceptable and was stored in the fridge at 4°C until ready for 
use. 
 
2.2.2 Protein Solution 
Lysozyme stock solutions were made to provide enough protein for the extent of 
this study.  This involved carefully weighing an imprecise amount of Lysozyme, 0.0462 
g, onto tared weigh-paper and quantitatively transferring into a 10 mL volumetric flask.  
Phosphate buffer (50 mM, pH=7.0) was used to wash any residual Lysozyme off the 
weigh-paper into the volumetric flask.  Lysozyme, in the volumetric flask, was diluted to 
the line with phosphate buffer (50 mM, pH=7.0) and the flask was capped and sealed 
with ParaFilm.  To facilitate the protein into solution, sonication was performed for 15 
min in addition to inversion and shaking the volumetric flask by hand.  After sonication, 
the protein solution was carefully transferred to Eppendorf tubes and stored in the freezer 
until needed.   
The concentration of stock Lysozyme was calculated by converting 0.0462 g of 
Lysozyme to moles of Lysozyme and then dividing by 0.0100 L.  To convert grams to 
moles, 0.0462 g of Lysozyme was divided by 14388 g/mol, the molecular weight of 
Lysozyme.  This value was then divided by 0.0100 L to determine the molarity, or 
concentration, of the stock Lysozyme.  Finally, this concentration was multiplied by 1000 
to express the concentration in mM, a unit easier to manipulate during future calculations.  
As result, the concentration of stock Lysozyme was determined to be 0.321 mM. 
To perform a reaction, one Eppendorf tube containing the stock Lysozyme was 
retrieved from the freezer and allowed to thaw out on ice for 20 min, on the counter for 
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20 min, and finally in the hand for a few minutes.  Once completely thawed, the protein 
solution was vortexed for 1 min to ensure homogeneity before being ready for use. 
For all studies involving the modification of Lysozyme by quinones, Lysozyme 
was fixed at a concentration of 0.010 mM.  Calculations were performed to determine the 
exact volume of stock Lysozyme to add to each reaction cuvette to obtain a Lysozyme 
concentration of 0.010 mM.  This was performed using Equation 2.2 where M1 is the 
concentration of stock Lysozyme (0.321 mM), V1 is the required aliquot of stock 
Lysozyme to be added to the reaction cuvette, M2 is the desired concentration of 
Lysozyme (0.010 mM), and V2 is the desired volume in the reaction cuvette (3000 μL).   
𝑀1𝑉1 = 𝑀2𝑉2   (Eq. 2.2) 
As result, 93.5 μL of stock Lysozyme was transferred to a 3 mL reaction cuvette 
containing phosphate buffer (50 mM) to achieve a Lysozyme concentration of 0.010 mM 
used for all studies. 
 
2.2.3 Quinone Solution 
Quinone solutions were made fresh for every reaction performed.  This involved 
weighing an imprecise amount of quinone on tared weigh-paper (a mass between 0.0100 
g and 0.0200 g) and quantitatively transferring to a 10 mL, 50 mL, or even 100 mL 
volumetric flask.  Phosphate buffer (50 mM) was used to wash any residual quinone off 
the weigh-paper into the volumetric flask.  Quinone, in the volumetric flask, was diluted 
to the line with phosphate buffer (50 mM) and capped and sealed with ParaFilm.  To 
facilitate the quinone into solution, sonication was performed for 10 min in addition to 
inversion and shaking the volumetric flask by hand.  Halfway through the sonication 
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procedure, the volumetric flask was removed, inverted to mix the solution, and then 
placed back into the sonicator.  After sonication, the quinone solution was transferred 
into a small holding beaker, covered with foil, and was ready for use. 
Considering the quinones used, PBQ dissolved easily into solution with the 
techniques mentioned above, but MBQ, CBQ, TCBQ, PhBQ, HNQ, ONQ, and PNQ 
required an additional agent to aide with their solubility.  For this, a 10% MeOH/90% 
phosphate buffer (50 mM) was used to help dissolve the quinones in the 10 mL, 50 mL, 
or 100 mL volumetric flasks.  It is important to note only the volumetric flask containing 
the quinone solution contained 10% MeOH.  Once the quinone, in solution, was 
transferred from the small holding beaker to the reaction cuvette, phosphate buffer (50 
mM) was used to bring the reaction cuvette up to volume.  When using the 10% 
MeOH/90% phosphate buffer solution for quinone preparation, the overall concentration 
of MeOH in the reaction cuvettes never exceeded 1%. 
During the sonication procedure, the concentration of quinone prepared in 
solution was calculated by converting the mass of quinone to moles of quinone and then 
dividing by the volume of the volumetric flask the quinone was dissolved in.  To convert 
grams of quinone to moles of quinone, the mass of quinone was divided by the molar 
mass of the quinone.  This value was then divided by the volume of the volumetric flask 
used to determine the molarity, or concentration, of the quinone in solution.  Finally, this 
concentration was multiplied by 1000 to express the concentration in mM, a unit easier to 
manipulate during future calculations. 
In addition, further calculations were performed during the sonication process to 
determine the exact volume of quinone solution to add to the reaction cuvette containing 
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Lyz (0.010 mM) and phosphate buffer (50 mM) to achieve the desired concentration of 
quinone in the reaction cuvette.  This was calculated using Equation 2.3 where, in this 
case, M1 is the actual concentration of the quinone solution prepared, V1 is the required 
aliquot of quinone solution to be added to the reaction cuvette, M2 is the desired 
concentration of quinone, and V2 is the desired volume in the reaction cuvette (3000 μL).   
𝑀1𝑉1 = 𝑀2𝑉2   (Eq. 2.3) 
 Since several concentrations of quinone were used across all studies, and the 
amount of quinone weighed out each time was different, the amount of quinone solution 
added to the reaction cuvette varied reaction to reaction.   
For PBQ, aliquot volumes were calculated for desired concentrations of 0.010 
mM, 0.050 mM, 0.10 mM, and 0.30 mM.  For MBQ, CBQ, TCBQ, PhBQ, HNQ, ONQ, 
PNQ, and studies involving PBQ at different temperatures or pH, aliquot volumes were 
calculated for a fixed concentration of 0.050 mM.  This concentration was determined to 
work with best when comparing different quinones or variables of reactions because it 
provided a concentration high enough to modify Lysozyme significantly. 
Once the calculated volume of quinone solution was added to the reaction cuvette 
containing Lyz (0.010 mM) and phosphate buffer (50 mM), the reaction began, the 
cuvette was placed into the fluorimeter for scanning, and the reaction time was kept on a 
scientific timer. 
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2.2.4 Fluorescence Spectroscopy & Anisotropy Measurements 
Fluorescence spectroscopy was performed using a Horiba Jobin Yvon Fluorolog 
spectrophotometer equipped with a Xenon lamp.  The excitation wavelength was fixed at 
280 nm with a 2 nm slit width to accommodate tryptophan and tyrosine residues in 
Lysozyme.  The resulting emission was recorded every 1 nm with a slit width of 2 nm 
over the range of 290-600 nm.  To draw correlations between all studies, each spectrum 
was normalized from 500-550 nm where little emission was recorded.  Microsoft Excel 
was used to analyze the data and to produce graphs to visualize the fluorescence spectra. 
All reactions were performed in a quartz cuvette in phosphate buffer (50 mM).  
The cuvette was equipped with a stir bar to ensure proper mixing and to minimize 
sedimentation of Lysozyme.  The stirring motion was set to the 3rd level of power as 
indicated on the fluorimeter.  Emission scanning lasted around 10 min and varied 
occasionally in duration due to mechanical motion inside of the fluorimeter.  Initial 
scanning, or reaction scanning, of Lysozyme occurred over 24 h with scans occurring 
every hour for that duration.  Post-modified Lysozyme was returned to a quartz cuvette 
after a 24 h dialysis and scanned an additional four times.  This resulting data was 
recorded, averaged, and analyzed in Microsoft Excel to produce the graphs presented in 
this study.  A control was produced by subjecting Lyz (0.010 mM) in phosphate buffer 
(50 mM) to the same procedure as every reaction performed. 
The software to operate the fluorimeter was FluorEssence by Horiba Jobin Yvon.  
This software was capable of automating fluorescence and anisotropy scans which were 
utilized to accomplish the 24 h scans of each study.  The first and second scans were 
always started manually with each consecutive scan being automatically started by the 
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programming.  Since each emission scan lasted around 10 min (600 s), the instrument 
was programmed to scan the reaction every 2997 s for 24 h to accomplish 24 h of 
scanning each hour.  Due to the mechanical motion of parts inside of the fluorimeter, an 
additional 3 s was added to accommodate the automated re-calibration of the instrument 
after each scan.  Due to fluctuations in voltage supplied to the instrument, the timing of 
the scans slightly varied for each reaction and occasionally needed to be reset during the 
reaction. 
The process of performing fluorescence measurements was performed in a similar 
manner for every reaction by following a pre-determined protocol.  To begin, the 
fluorimeter was turned on by first switching on the water bath, the fan, the lamp, and then 
the software PC.  The lamp was allowed to warm up for 1 h before any measurements 
took place.  The instrument was initialized by selecting to perform a spectra study, 
specifically an emission study, and then by executing a trial scan (C1-Trial) with the 
cuvette containing only Lysozyme and phosphate buffer (50 mM).  Once the initialization 
was complete and the trial scan was acceptable, the software was used to program the 
instrument for fluorescence measurements.  A scientific timer was obtained and started as 
soon as the aliquot of quinone was administered to the reaction cuvette containing 
Lysozyme and phosphate buffer.  After this, the reaction cuvette was capped, the sides 
wiped with Kimwipes, inverted 3 times, and placed in the fluorimeter for scanning.  Once 
securely positioned inside the fluorimeter, the fluorescence scanning was started and the 
time on the scientific timer was recorded.  This time was the delay between the actual 
start of the reaction of Lysozyme with quinone and the fluorescence scanning of the 
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reaction.  In addition, the time of day was recorded to be able to monitor the start and 
stop of each consecutive measurement every hour. 
Post-modified Lysozyme fluorescence measurements were performed using a 
different programmed scanning procedure as initial scanning.  In these scans, modified 
Lysozyme was scanned four times in the time frame of 1 h at 37°C.  Once these scans 
were complete, the cuvette was removed from the fluorimeter and the instrument was 
shut down in the reverse order in was turned on.  This concluded the use of fluorescence 
spectroscopy to measure the modification of Lysozyme induced by quinones. 
In addition to fluorescence measurements, anisotropy measurements were 
performed as well during initial and post-modified scanning of Lysozyme.  Appendix A 
shows anisotropy measurements for each study performed using Lysozyme.  A general 
trend can be seen in each graph indicating the correlation between increasing 
modification of Lysozyme and increasing anisotropy values of Lysozyme. 
 
2.2.5 UV-VIS Spectroscopy 
UV-VIS spectroscopy was performed using a double-beam UV-1800 Shimadzu 
UV Spectrophotometer.  The instrument was always allowed to warm up for 20 min 
before any measurements took place.  Excitation was achieved using a D2/W lamp with 
the resulting spectra recorded at 1 nm sampling intervals over the range of 200-700 nm 
with the scan speed set to fast.  The slit width was 1.0 nm and the D2/W light change was 
set at 340.8 nm.  The instrument was auto-zeroed and baselined prior to every scan to 
account for background noise.  Microsoft Excel was used to analyze the data recorded 
and to produce the graphs presented in this study.   
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Immediately after fluorescence scanning was complete, the cuvette was 
transferred into the UV-VIS spectrophotometer for analysis.  Absorbance of the analyte 
was recorded and immediately processed on screen using the software UV Probe 2.33.  A 
reference cell containing phosphate buffer (50 mM, pH=7.0) was prepared at the 
beginning of the study and was used for every reaction throughout the study.  This 
insured the absorbance calculated by the instrument was solely from Lysozyme and any 
bound or unbound quinone.  Pre-dialysis Lysozyme exhibited larger absorbance than 
post-dialysis Lysozyme due to unbound quinone in solution absorbing light.  Removal of 
unbound quinone by dialysis reduced the absorbance of the analyte and produced a more 
accurate representation of modified Lysozyme. 
 All UV-VIS measurements were performed in the same manner and used to 
measure the amount of modification (by adduct formation) of Lysozyme. 
 
2.2.6 Dialysis 
To accurately measure the modification of Lysozyme induced by quinones, 
dialysis was performed to remove unbound quinone that was not covalently bonded to 
Lysozyme.  Spectroscopically measuring Lysozyme with bound quinone alone gives 
clear understanding of the modification of Lysozyme induced by quinones.   
Dialysis was performed using a 5 mL Float-A-Lyzer purchased from Spectrum 
Laboratories.  The membrane, with a molecular cutoff of 3.5 kDa, allowed unbound 
quinone to freely exit through the membrane.  Lysozyme, with a molecular mass of 14.3 
kDa, or modified Lysozyme, with a slightly higher molecular mass, remained inside of 
the dialysis membrane along with any quinone bound to the protein via ionic bonding, 
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covalent bonding, or H-bonding.  Before use, each dialysis membrane was thoroughly 
soaked, washed, and rinsed with DI water and then temporarily held in phosphate buffer 
solution (50 mM) kept at 4°C.  Before the reaction solution could be transferred into the 
dialysis membrane, the membrane was emptied of phosphate buffer solution to insure 
proper concentration of the protein and quinone in solution.  Once the reaction solution 
was carefully transferred from the reaction cuvette to the dialysis membrane by a 
disposable pipette, the dialysis membrane was placed in 900 mL of phosphate buffer 
solution and kept at 4°C for 24 h.  Facilitation of unbound quinone out of the dialysis 
membrane was accelerated by the concentration gradient between the phosphate buffer 
solution and the reaction solution as well as by stirring using a stir bar.  Since the 
concentration of quinone outside of the dialysis membrane was less than the 
concentration of quinone inside of the dialysis membrane, simple diffusion occurred and 
the unbound quinone exited the dialysis membrane.  This was further accelerated by 
changing out the phosphate buffer solution three times, typically every 2.5 h.  By doing 
this, the concentration gradient became smaller each time and diffusion continued to take 
place.  After three buffer changes, and considering the volume of reaction solution to 
phosphate buffer solution, it is safe to assume all unbound quinone had been washed 
from the reaction solution. 
After 24 h of dialysis, the contents in the dialysis membrane were returned to a 
clean reaction cuvette and placed in the fluorimeter for post-dialysis fluorescence 
scanning.  By removal of unbound quinone in solution, the modification of Lysozyme by 
bound quinone only was measured and quantified by fluorescence and UV-VIS 
spectroscopy.  
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2.3 Results and Discussion 
 
The results of several reactions involving Lysozyme are presented below.  Six different 
studies were conducted: (1) a study with PBQ at various concentrations, (2) a study with 
PBQ incubated for various lengths of time, (3) a study involving certain substituents on 
PBQ, (4) a study involving naphthoquinones, and (5-6) studies focused on the pH and 
temperature dependence of PBQ.  Fluorescence and UV-VIS graphs are included for each 
study.  The graphs depict the fluorescence intensity and absorbance of post-dialysis 
Lysozyme.  Post-dialysis Lysozyme (i.e. modified Lysozyme) refers to Lysozyme which 
has completed a 24 h dialysis and contains only Lysozyme and any bound quinone to the 
protein.   
Normalized integrated fluorescence intensity (NIFI) values were obtained by 
selecting a range of wavelengths and calculating the area under the curve of each 
fluorescence spectrum.  Two separate wavelength ranges were chosen for all calculations 
of NIFI.  The integration range of 300-410 nm spans the entire fluorescence area while 
the integration range of 320-360 nm narrows in on the maximum fluorescence intensity 
for each reaction.  This was done to account for minor peaks in the fluorescence spectra 
and to measure uniformity when comparing results.  Two reference NIFIs were used, Lyz 
(0.010 mM) for all studies except those with pH or temperature alterations, and Lyz + 
PBQ (0.050 mM) (pH=7.0, 37°C) for the studies with pH or temperature alterations.  To 
quantify the modification of Lysozyme from different studies, a reduced integrated 
fluorescence intensity (RIFI) value was calculated by dividing the NIFI of the study in 
question by the reference NIFI, converting to a percentage, and then subtracting from 
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100%.  Reference NIFIs have RIFIs of 0% since 100%-100% = 0% and negative RIFIs 
represent an increase in fluorescence intensity since the corresponding NIFI is greater 
than the reference NIFI. 
Through observation of a reduction of fluorescence intensity and an increase in 
absorbance, modification of Lysozyme was confirmed from the results of these studies. 
 
2.3.1 Lysozyme Modifications Induced by PBQ at Various Concentrations 
In this study, Lyz (0.010 mM) was treated with PBQ (0.010, 0.050, 0.10, or 0.30 
mM) and allowed to react while being monitored using fluorescence for 24 h.  Following 
the 24 h incubation, dialysis was performed for an additional 24 h followed by a final 
spectroscopic measurement of modified Lysozyme.  All reactions were performed in a 
phosphate buffer (50 mM) at 37°C and pH=7.0 to mimic physiological conditions.  To 
investigate the influence of using methanol for increasing quinone solubility, one reaction 
was performed using a 10% MeOH/90% phosphate buffer when preparing the quinone 
solution. 
Table 2.1 lists RIFI values calculated over 300-410 nm and 320-360 nm in 
addition to absorbance values for each reaction performed in this study.  Figure 2.1 shows 
the fluorescence intensity of Lysozyme and Lysozyme modified by PBQ (0.010, 0.050, 
0.10, or 0.30 mM) for 24 h at 37°C.  All spectra were normalized in the 500-550 nm 
range where little emission is present to ensure proper comparison.  Figure 2.2 shows the 
absorbance of Lysozyme and Lysozyme modified by PBQ (0.010, 0.050, 0.10, or 0.30 
mM) for 24 h at 37°C.    
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Table 2.1 RIFI of Lyz (0.010 mM) and Lyz (0.010 mM) modified by PBQ (0.010, 
0.050, 0.10, or 0.30 mM) for 24 h at 37°C.  Absorbance at 346 nm of Lyz 
(0.010 mM) and Lyz (0.010 mM) modified by PBQ (0.010, 0.050, 0.10, or 
0.30 mM) for 24 h at 37°C. 
Reaction RIFIa (%) RIFIb (%) A346 (a.u.) 
Lyz (0.010 mM) 0 0 -0.001 
Lyz + PBQ (0.010 mM) 28 29 0.039 
Lyz + PBQ (0.050 mM) MeOH 53 53 0.082 
Lyz + PBQ (0.050 mM) 57 58 0.094 
Lyz + PBQ (0.10 mM) (150526) 65 66 0.125 
Lyz + PBQ (0.10 mM) (150713) 66 67 0.123 
Lyz + PBQ (0.10 mM) (150513) 70 71 No Data 
Lyz + PBQ (0.30 mM) 81 82 0.134 
a integration between 300-410 nm 
b integration between 320-360 nm 
 
 
 
Figure 2.1 Fluorescence spectra of Lyz (0.010 mM) and Lyz (0.010 mM) modified 
by PBQ (0.010, 0.050, 0.10, or 0.30 mM) for 24 h at 37°C. 
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Figure 2.2 UV-VIS spectra of Lyz (0.010 mM) and Lyz (0.010 mM) modified by 
PBQ (0.010, 0.050, 0.10, or 0.30 mM) for 24 h at 37°C. 
 
As seen in Figure 2.1, the fluorescence intensity decreases as the concentration of 
PBQ increases in the reaction solution.  From the results of previous studies, it was found 
exposure of Lysozyme to PBQ elicits protein oligomerization over time.  This 
oligomerization is believed to cause a decrease in the fluorescence intensity of 
Lysozyme.  To quantify the degree of modification of Lysozyme, RIFI values were 
calculated using Lyz (0.010 mM) as the reference NIFI.  As seen in Table 2.1, the RIFI 
increases as the concentration of PBQ in the reaction solution increases.  This is 
interpreted as an increase in the modification of Lysozyme upon exposure to increasing 
concentration of PBQ.  Considering all reactions performed in this study, Table 2.1 
shows no more than a 1% difference in RIFI values calculated over the two integration 
ranges. 
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As seen in Figure 2.2, the absorbance in the 300-410 nm range increases as the 
concentration of PBQ increases in the reaction solution.  Since quinone absorbs in this 
range, and any free quinone has already been removed through dialysis, the increase in 
absorbance is believed to be result of PBQ covalently bonded to Lysozyme.  To monitor 
this, Table 2.1 shows the absorbance at 346 nm of Lysozyme and modified Lysozyme.  
From these results, increasing the concentration of PBQ increases the overall absorbance 
of Lysozyme.  This is interpreted as an increase in the modification (in this case, adduct 
formation) of Lysozyme upon increasing concentration of PBQ. 
When considering the effect of using 10% MeOH during quinone preparation, 
Table 2.1 shows RIFI values for Lyz + PBQ (0.050 mM) MeOH and Lyz + PBQ (0.050 
mM) to be less than 5% of each other.  Figures 2.1 and 2.2 support this by showing a 
slight difference in the fluorescence and absorbance spectra of the two reactions.  
Overall, it can be concluded that the use of 10% MeOH is minimal in affecting the 
modification of Lysozyme when exposed to PBQ. 
Due to some experimental errors during the reaction PBQ (0.10 mM) (150513), 
the UV-VIS spectrum was not recorded.  As result, the reaction was duplicated once, then 
twice, when differences were observed in the NIFI between the first and second run.  The 
RIFI for the following two reactions Lyz + PBQ (0.10 mM) (150526) and Lyz + PBQ 
(0.10 mM) (150713) were almost identical and varied only by 1%.  This confirmed the 
difference in NIFI of the first reaction involving Lysozyme incubated with PBQ (0.10 
mM) as our method is reliable up to 3% difference in RIFI.  As result of the duplications, 
it is believed Lysozyme incubated with PBQ (0.10 mM) yields a modification of 
Lysozyme by 65-67%. 
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 In summary, Lysozyme modification was found to be increasing with the 
concentration of PBQ.  In conjunction with the SDS-PAGE data presented in Chapter 1 
[Greve & Kim, 2015], and similar to what was observed during previous studies with 
Ribonuclease A, this study shows PBQ exhibits its modifying capabilities through both 
induction of protein oligomerization and adduct formation. 
 
2.3.2 Lysozyme Modifications Induced by PBQ Over Various Lengths of Time 
In this study, Lyz (0.010 mM) was treated with PBQ (0.050 mM) and allowed to 
react while being monitored using fluorescence for 0, 1, 2, 3, and 24 h.  Following each 
incubation, dialysis was performed for 24 h followed by a final spectroscopic 
measurement of modified Lysozyme.  All reactions were performed in a phosphate buffer 
(50 mM) at 37°C and pH=7.0 to mimic physiological conditions. 
Table 2.2 lists RIFI values calculated over 300-410 nm and 320-360 nm in 
addition to absorbance values for each reaction performed in this study.  Figure 2.3 shows 
the fluorescence intensity of Lysozyme and Lysozyme modified by PBQ (0.050 mM) for 
0, 1, 2, 3, and 24 h at 37°C.  All spectra were normalized in the 500-550 nm range where 
little emission is present to ensure proper comparison.  Figure 2.4 shows the absorbance 
of Lysozyme and Lysozyme modified by PBQ (0.050 mM) for 0, 1, 2, 3, and 24 h at 
37°C.   
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Table 2.2 RIFI of Lyz (0.010 mM) and Lyz (0.010 mM) modified by PBQ (0.050 
mM) for 0 h, 1 h, 2 h, 3 h, and 24 h at pH=7.0 and 37°C.  Absorbance at 
346 nm of Lyz (0.010 mM) and Lyz (0.010 mM) modified by PBQ (0.050 
mM) for 0 h, 1 h, 2 h, 3 h, and 24 h at pH=7.0 and 37°C. 
Reaction RIFIa (%) RIFIb (%) A346 (a.u.) 
Lyz + PBQ (0.050 mM) 1 h -17 -18 -0.009 
Lyz + PBQ (0.050 mM) 2 h -13 -15 -0.007 
Lyz + PBQ (0.050 mM) 0 h -13 -13 -0.009 
Lyz (0.010 mM) 0 h  -12 -12 0.003 
Lyz + PBQ (0.050 mM) 3 h -5 -5 0.007 
Lyz (0.010 mM) 0 0 -0.001 
Lyz + PBQ (0.050 mM) 57 58 0.094 
a integration between 300-410 nm 
b integration between 320-360 nm 
 
 
 
Figure 2.3 Fluorescence spectra of Lyz (0.010 mM) and Lyz (0.010 mM) modified 
by PBQ (0.050 mM) for 0 h, 1 h, 2 h, 3 h, and 24 h at pH=7.0 and 37°C. 
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Figure 2.4 UV-VIS spectra of Lyz (0.010 mM) and Lyz (0.010 mM) modified by 
PBQ (0.050 mM) for 0 h, 1 h, 2 h, 3 h, and 24 h at pH=7.0 and 37°C. 
 
As seen in Figure 2.3, the fluorescence intensity of Lysozyme and Lysozyme 
modified with PBQ increases during the first three hours of incubation.  Since each 
reaction was performed for a specific amount of time, the results were assumed to vary 
according to the incubation time.  The resulting increase in fluorescence intensity could 
be due to adduct formation or redox cycling of PBQ, both which may increase the 
quantum yield of Lysozyme.  Since redox cycling results in higher concentrations of the 
reduced form of PBQ, the fluorescence intensity would be expected to increase as 
reduced PBQ exhibits fluorescence.  No protein oligomerization (induced by PBQ) was 
assumed to occur during the first three hours as the fluorescence intensity did not 
decrease.  To quantify the degree of modification of Lysozyme, RIFI values were 
calculated using Lyz (0.010 mM) as the reference NIFI.  As seen in Table 2.2, the RIFI 
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decreases to a maximum during the first hour of incubation and then begins to increase 
over time.  From the results of this study, one could safely assume the RIFI would 
continue increasing for the next several hours until similar results of the reactions Lyz 
(0.010 mM) and Lyz + PBQ (0.050 mM) in the previous study were observed.  
Considering all reactions performed in this study, Table 2.2 shows no more than a 2% 
difference in RIFI values calculated over the two integration ranges. 
 As seen in Figure 2.4, little to no absorbance occurs in the 300-410 nm range 
during the first three hours of incubation.  Since quinone absorbs in this range, and any 
free quinone has already been removed through dialysis, little adduct formation is 
believed to occur during the first three hours of incubation.  To monitor this, Table 2.2 
shows the absorbance at 346 nm of Lysozyme and modified Lysozyme.  From this data, 
it is confirmed that three hours of incubation is not enough time to produce lasting 
modification of Lysozyme through adduct formation. 
 When considering the reaction Lyz (0.010 mM) 0 h, Figure 2.3 and Table 2.2 
indicate an increase in fluorescence intensity when compared to the reaction Lyz (0.010 
mM).  This increase could be due to the lack of protein-protein interaction which would 
occur over 24 h of incubation.  Since the reaction Lyz (0.010 mM) 0 h underwent an 
immediate dialysis after Lysozyme was placed in solution, the results indicate the 
fluorescence intensity of Lysozyme increases and then decreases over time. 
 Considering the results of SDS-PAGE studies presented in Chapter 1 [Greve & 
Kim, 2015], Lysozyme modification was expected during the first three hours of 
incubation with PBQ.  From the results of these studies, fluorescence and UV-VIS 
spectroscopy did not support previous results regarding the oligomerization of Lysozyme 
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during the first three hours of incubation with PBQ although the concentration of 
Lysozyme used in SDS-PAGE studies were higher.  These results suggest the 
fluorescence intensity of Lysozyme is unaffected by PBQ within the first three hours of 
incubation but protein oligomerization, initiated by PBQ, still occurs. 
 
2.3.3 Lysozyme Modifications Induced by Substituted Quinones 
In this study, Lyz (0.010 mM) was treated with MBQ (0.050 mM), PBQ (0.050 
mM), PhBQ (0.050 mM), CBQ (0.050 mM), and TCBQ (0.050 mM) and allowed to react 
while being monitored using fluorescence for 24 h.  Following the 24 h incubation, 
dialysis was performed for an additional 24 h followed by a final spectroscopic 
measurement of modified Lysozyme.  All reactions were performed in a phosphate buffer 
(50 mM) at 37°C and pH=7.0 to mimic physiological conditions. 
Table 2.3 lists RIFI values calculated over 300-410 nm and 320-360 nm in 
addition to absorbance values for each reaction performed in this study.  Figure 2.5 shows 
the fluorescence intensity of Lysozyme and Lysozyme modified by MBQ (0.050 mM), 
PBQ (0.050 mM), PhBQ (0.050 mM), CBQ (0.050 mM), and TCBQ (0.050 mM) for 24 
h at 37°C.  All spectra were normalized in the 500-550 nm range where little emission is 
present to ensure proper comparison.  Figure 2.6 shows the absorbance of Lysozyme and 
Lysozyme modified by MBQ (0.050 mM), PBQ (0.050 mM), PhBQ (0.050 mM), CBQ 
(0.050 mM), and TCBQ (0.050 mM) for 24 h at 37°C. 
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Table 2.3 RIFI of Lyz (0.010 mM) and Lyz (0.010 mM) modified by MBQ (0.050 
mM), PBQ (0.050 mM), PhBQ (0.050 mM), CBQ (0.050 mM), and 
TCBQ (0.050 mM) for 24 h at 37°C.  Absorbance at 346 nm of Lyz (0.010 
mM) and Lyz (0.010 mM) modified by MBQ (0.050 mM), PBQ (0.050 
mM), PhBQ (0.050 mM), CBQ (0.050 mM), and TCBQ (0.050 mM) for 
24 h at 37°C. 
 
Reaction RIFIa (%) RIFIb (%) A346 (a.u.) 
Lyz (0.010 mM) 0 0 -0.001 
Lyz + MBQ (0.050 mM) 36 37 0.019 
Lyz + PBQ (0.050 mM) 57 58 0.094 
Lyz + PhBQ (0.050 mM) 60 61 0.042 
Lyz + CBQ (0.050 mM) 66 67   0.122 
Lyz + TCBQ (0.50 mM) 78 79 0.173 
a integration between 300-410 nm 
b integration between 320-360 nm 
 
 
Figure 2.5 Fluorescence spectra of Lyz (0.010 mM) and Lyz (0.010 mM) modified 
by MBQ (0.050 mM), PBQ (0.050 mM), PhBQ (0.050 mM), CBQ (0.050 
mM), and TCBQ (0.050 mM) for 24 h at 37°C. 
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Figure 2.6 UV-VIS spectra of Lyz (0.010 mM) and Lyz (0.010 mM) modified by 
MBQ (0.050 mM), PBQ (0.050 mM), PhBQ (0.050 mM), CBQ (0.050 
mM), and TCBQ (0.050 mM) for 24 h at 37°C. 
 
As seen in Figure 2.5, the fluorescence intensity of Lysozyme decreases upon 
exposure to substituted quinones.  MBQ was found to cause the smallest decrease in 
fluorescence intensity, followed by PBQ, PhBQ, CBQ, and TCBQ.  This result is 
believed to be linked with the electron donating and electron withdrawing properties of 
each substituent.  The substituents that are electron donating cause less modification of 
Lysozyme than the substituents that are electron withdrawing.  MBQ, and to a lesser 
extent, PhBQ, have electron donating properties and are found to elicit moderate 
modification of Lysozyme.  CBQ and TCBQ have electron withdrawing properties and 
are found to elicit severe modification of Lysozyme.  To quantify the degree of 
modification of Lysozyme, RIFI values were calculated using Lyz (0.010 mM) as the 
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reference NIFI.  As seen in Table 2.3, the RIFI increases as each substituent becomes 
more electron withdrawing.  This is interpreted as an increase in modification of 
Lysozyme by molecules that possess electron withdrawing substituents.  Considering all 
reactions performed in this study, Table 2.3 shows no more than a 1% difference in RIFI 
values calculated over the two integration ranges. 
 As seen in Figure 2.6, the absorbance in the 300-410 nm range increases in the 
same manner as mentioned above.  Since quinone absorbs in this range, and any free 
quinone has already been removed through dialysis, the increase in absorbance is 
believed to be result of substituted quinones covalently bonded to Lysozyme.  To monitor 
this, Table 2.3 shows the absorbance at 346 nm of Lysozyme and modified Lysozyme.  
From these results, as each substituent increases in electron withdrawing capability, the 
absorbance increases as well.  This is interpreted as an increase in the modification (in 
this case, adduct formation) of Lysozyme upon exposure to substituted quinones with 
electron withdrawing properties. 
 Considering the reaction with PhBQ (0.050 mM), Figures 2.5 and 2.6 show 
interesting results when examining the order of modification each substituent produces.  
Figure 2.5 shows PhBQ to cause a greater decrease in fluorescence intensity than PBQ 
while Figure 2.6 shows PhBQ to exhibit less absorbance than PBQ.  The results in 
previous studies have been found to have correlating results between fluorescence and 
UV-VIS spectra.  In other words, as the fluorescence intensity decreases, the absorbance 
increases.  PhBQ shows interesting results because its absorbance is less than what it 
supposedly should be.  This is particularly interesting due to the structure of PhBQ and its 
potential energy absorbing capability. 
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 In summary, Lysozyme modification was found to be increasing with the electron 
withdrawing capability of each substituted quinone.  In conjunction with the SDS-PAGE 
data presented in Chapter 1 [Greve & Kim, 2015], this study shows substituted quinones 
exhibit modifying capabilities through both induction of protein oligomerization and 
adduct formation. 
 
2.3.4 Lysozyme Modifications Induced by Naphthoquinones 
In this study, Lyz (0.010 mM) was treated with HNQ (0.050 mM), PNQ (0.050 
mM), and ONQ (0.050 mM) and allowed to react while being monitored using 
fluorescence for 24 h.  Following the 24 h incubation, dialysis was performed for an 
additional 24 h followed by a final spectroscopic measurement of the modified 
Lysozyme.  All reactions were performed in a phosphate buffer (50 mM) at 37°C and 
pH=7.0 to mimic physiological conditions. 
Table 2.4 lists RIFI values calculated over 300-410 nm and 320-360 nm in 
addition to absorbance values for each reaction performed in this study.  Figure 2.7 shows 
the fluorescence intensity of Lysozyme and Lysozyme modified by HNQ (0.050 mM), 
PNQ (0.050 mM), and ONQ (0.050 mM) for 24 h at 37°C.  All spectra were normalized 
in the 500-550 nm range where little emission is present to ensure proper comparison.  
Figure 2.8 shows the absorbance of Lysozyme and Lysozyme modified by HNQ (0.050 
mM), PNQ (0.050 mM), and ONQ (0.050 mM) for 24 h at 37°C. 
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Table 2.4 RIFI of Lyz (0.010 mM) and Lyz (0.010 mM) modified by HNQ (0.050 
mM), PNQ (0.050 mM), and ONQ (0.050 mM) for 24 h at 37°C.  
Absorbance at 346 nm of Lyz (0.010 mM) and Lyz (0.010 mM) modified 
by HNQ (0.050 mM), PNQ (0.050 mM), and ONQ (0.050 mM) for 24 h at 
37°C. 
 
Reaction RIFIa (%) RIFIb (%) A346 (a.u.) 
Lyz (0.010 mM) 0 0 -0.001 
Lyz + HNQ (0.050 mM) 29 29 0.025 
Lyz + PNQ (0.050 mM) 43 43 0.014 
Lyz + ONQ (0.050 mM) 60 61 0.081 
a integration between 300-410 nm 
b integration between 320-360 nm 
 
 
 
Figure 2.7 Fluorescence spectra of Lyz (0.010 mM) and Lyz (0.010 mM) modified 
by HNQ (0.050 mM), PNQ (0.050 mM), and ONQ (0.050 mM) for 24 h at 
37°C. 
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Figure 2.8 UV-VIS spectra of Lyz (0.010 mM) and Lyz (0.010 mM) modified by 
HNQ (0.050 mM), PNQ (0.050 mM), and ONQ (0.050 mM) for 24 h at 
37°C. 
 
As seen in Figure 2.7, the fluorescence intensity of Lysozyme decreases upon 
exposure to naphthoquinones.  From the results of previous SDS-PAGE studies 
mentioned in Chapter 1, naphthoquinones have been found to produce little, if not any, 
protein modifying behavior [Smith & Kim, 2015].  In this study, HNQ, PNQ, and ONQ 
were all found to produce modification of Lysozyme.  To quantify the degree of 
modification of Lysozyme, RIFI values were calculated using Lyz (0.010 mM) as the 
reference NIFI.  As seen in Table 2.4, ONQ produced the largest RIFI followed by PNQ 
and HNQ, respectively.  This is interpreted as HNQ causing the least modification of 
Lysozyme and ONQ causing the greatest modification of Lysozyme.  Considering all 
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reactions performed in this study, Table 2.4 shows no more than a 1% difference in RIFI 
values calculated over the two integration ranges. 
 As seen in Figure 2.8, the absorbance in the 300-410 nm range increases as usual 
for quinone-incubated solutions with an additional increase in the 400-500 nm range due 
to the color of solution.  Since naphthoquinone absorbs in this range, and any free 
naphthoquinone has already been removed through dialysis, the increase in absorbance is 
believed to be result of naphthoquinone covalently bonded to Lysozyme.  To monitor 
this, Table 2.4 shows the absorbance at 346 nm of Lysozyme and modified Lysozyme.  
From these results, ONQ shows the largest absorbance, followed by HNQ then PNQ, 
respectively.  This is interpreted as ONQ causing the largest degree of Lysozyme 
modification and HNQ and PNQ exhibiting a similar phenomenon as seen in the study 
with quinone substituents. 
 Considering the structure of each naphthoquinone used in this study, the results of 
this study demonstrate how the position of the double bonded oxygen on the 
naphthoquinone plays a role in its protein modifying capability.  Figures 2.7 and 2.8 
show ONQ to elicit the greatest modification of Lysozyme and PNQ and HNQ to elicit 
varying degrees of modification of Lysozyme.  Since the UV-VIS absorbance of PNQ in 
the 300-410 nm range is relatively absent, it can be assumed PNQ does not exhibit its 
protein modifying behavior through adduct formation but rather by induction of protein 
oligomerization.  In contrast, since the UV-VIS absorbance of HNQ in the 300-410 nm 
range is prominent, and the RIFI of HNQ is less than PNQ, it can be assumed HNQ 
exhibits its protein modifying behavior through adduct formation rather than induction of 
protein oligomerization.  Going further, the double bonded oxygen at the ortho- position 
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seems to elicit the largest degree of Lysozyme modification.  Comparing HNQ with 
PNQ, it appears the hydroxyl group on HNQ favors adduct formation while the double 
bonded oxygen at the para- position acts much like PBQ regarding induction of protein 
oligomerization. 
 In summary, Lysozyme modification, regardless of degree, was found with all 
naphthoquinones used in this study.  Consistent with SDS-PAGE data presented in 
Chapter 1 [Smith & Kim, 2015], this study suggests naphthoquinones, specifically ONQ, 
HNQ, and PNQ, exhibit modifying capabilities towards Lysozyme through both 
induction of protein oligomerization and adduct formation. 
 
2.3.5 Lysozyme Modifications Induced by PBQ at Various pH 
In this study, Lyz (0.010 mM) was treated with PBQ (0.050 mM) and allowed to 
react at pH=6.0, pH=7.0, and pH=8.0 while being monitored using fluorescence for 24 h.  
Following the 24 h incubation, dialysis was performed for an additional 24 h followed by 
a final spectroscopic measurement of modified Lysozyme.  All reactions were performed 
in a phosphate buffer (50 mM) at 37°C. 
 Table 2.5 lists RIFI values calculated over 300-410 nm and 320-360 nm in 
addition to absorbance values for each reaction performed in this study.  Figure 2.9 shows 
the fluorescence intensity of Lysozyme and Lysozyme modified by PBQ (0.050 mM) at 
pH=6.0, pH=7.0, and pH=8.0 for 24 h at 37°C.  All spectra were normalized in the 500-
550 nm range where little emission is present to ensure proper comparison.  Figure 2.10 
shows the absorbance of Lysozyme and Lysozyme modified by PBQ (0.050 mM) at 
pH=6.0, pH=7.0, and pH=8.0 for 24 h at 37°C.  
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Table 2.5 RIFI of Lyz (0.010 mM) and Lyz (0.010 mM) modified by HNQ (0.050 
mM), PNQ (0.050 mM), and ONQ (0.050 mM) for 24 h at 37°C.  
Absorbance at 346 nm of Lyz (0.010 mM) and Lyz (0.010 mM) modified 
by HNQ (0.050 mM), PNQ (0.050 mM), and ONQ (0.050 mM) for 24 h at 
37°C. 
Reaction RIFIa (%) RIFIb (%) A346 (a.u.) 
Lyz + PBQ (0.050 mM) pH=6.0 -20 -21 0.049 
Lyz + PBQ (0.050 mM) pH=7.0 0 0 0.094 
Lyz + PBQ (0.050 mM) pH=8.0 47 48 0.171 
a integration between 300-410 nm 
b integration between 320-360 nm 
 
 
 
Figure 2.9 Fluorescence spectra of Lyz (0.010 mM) modified by PBQ (0.050 mM) at 
pH=6.0, pH=7.0, and pH=8.0 for 24 h at 37°C. 
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Figure 2.10 UV-VIS spectra of Lyz (0.010 mM) modified by PBQ (0.050 mM) at 
pH=6.0, pH=7.0, and pH=8.0 for 24 h at 37°C. 
 
As seen in Figure 2.9, the fluorescence intensity decreases as the pH of the 
reaction solution increases.  This is believed to be due to increasing the nucleophilic 
character of the protein as the pH increases and therefore increasing the association of 
Lysozyme and PBQ.  To quantify this degree of modification of Lysozyme, RIFI values 
were calculated using Lyz + PBQ (0.050 mM) pH=7.0 as the reference NIFI.  As seen in 
Table 2.5, the RIFI increases as the pH increases and decreases as the pH decreases.  This 
is interpreted as an increase of modification of Lysozyme when increasing the pH and a 
decrease of modification of Lysozyme when decreasing the pH.  Obviously, incubating 
Lysozyme with PBQ regardless of the pH causes a modification of Lysozyme.  However, 
considering conditions at physiological pH, a decrease in pH causes less modification of 
Lysozyme and an increase in pH causes a greater modification of Lysozyme.  
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Considering all reactions performed in this study, Table 2.5 shows no more than a 1% 
difference in RIFI values calculated over the two integration ranges. 
 As seen in Figure 2.10, the absorbance in the 300-410 nm range increases as the 
pH of the reaction solution increases.  Since quinone absorbs in this range, and any free 
quinone has already been removed through dialysis, the increase and decrease in 
absorbance is believed to be result of PBQ covalently bonded to Lysozyme.  To monitor 
this, Table 2.5 shows the absorbance at 346 nm of Lysozyme incubated with PBQ at 
pH=6.0, pH=7.0, and pH=8.0.  From these results, increasing the pH of the reaction 
solution increases the absorbance.  Again, any incubation of Lysozyme with PBQ will 
cause an increase in the overall absorbance of Lysozyme, however, in this study, 
comparisons to physiological pH were made, and increases and decreases in absorbance 
were noted as result. 
 Considering the results of this study, several assumptions can be made.  For 
example, increasing the pH of solution gives rise to increasing deprotonation of 
Lysozyme which results in greater attractive forces between PBQ and Lysozyme.  In 
addition, decreasing the pH of solution gives rise to increasing protonation of Lysozyme 
and PBQ which results in greater repulsive forces between PBQ and Lysozyme. 
 In summary, Lysozyme modification was found to be dependent on varying the 
pH of the reaction.  This study suggests PBQ exhibits its modifying capabilities through 
both induction of protein oligomerization and adduct formation at multiple pH values. 
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2.3.6 Lysozyme Modifications Induced by PBQ at Various Temperatures 
In this study, Lyz (0.010 mM) was treated with PBQ (0.050 mM) and allowed to 
react at 27°C, 37°C, and 42°C while being monitored using fluorescence for 24 h.  
Following the 24 h incubation, dialysis was performed for an additional 24 h followed by 
a final spectroscopic measurement of modified Lysozyme.  All reactions were performed 
in a phosphate buffer (50 mM) at pH=7.0. 
Table 2.6 lists RIFI values calculated over 300-410 nm and 320-360 nm in 
addition to absorbance values for each reaction performed in this study.  Figure 2.11 
shows the fluorescence intensity of Lysozyme and Lysozyme modified by PBQ (0.050 
mM) at 27°C, 37°C, and 42°C for 24 h at pH=7.0.  All spectra were normalized in the 
500-550 nm range where little emission is present to ensure proper comparison.  Figure 
2.12 shows the absorbance of Lysozyme and Lysozyme modified by PBQ (0.050 mM) at 
27°C, 37°C, and 42°C for 24 h at pH=7.0. 
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Table 2.6 RIFI of Lyz (0.010 mM) modified by PBQ (0.050 mM) at 27°C, 37°C, 
and 42°C for 24 h at pH=7.0.  Absorbance at 346 nm of Lyz (0.010 mM) 
modified by PBQ (0.050 mM) at 27°C, 37°C, and 42°C for 24 h at 
pH=7.0. 
Reaction RIFIa (%) RIFIb (%) A346 (a.u.) 
Lyz + PBQ (0.050 mM) 27°C -32 -34 0.057 
Lyz + PBQ (0.050 mM) 37°C 0 0 0.094 
Lyz + PBQ (0.050 mM) 42°C 21 22 0.119 
a integration between 300-410 nm 
b integration between 320-360 nm 
 
 
 
Figure 2.11 Fluorescence spectra of Lyz (0.010 mM) modified by PBQ (0.050 mM) at 
27°C, 37°C, and 42°C for 24 h at pH=7.0. 
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Figure 2.12 UV-VIS spectra of Lyz (0.010 mM) modified by PBQ (0.050 mM) at 
27°C, 37°C, and 42°C for 24 h at pH=7.0. 
 
As seen in Figure 2.11, the fluorescence intensity decreases as the temperature of 
the reaction solution increases.  This is believed to be due to speeding up the kinetics of 
the reaction and possibly altering the shape and size of Lysozyme by changing the 
temperature.  When Lysozyme and PBQ in solution are moving around at a greater speed 
due to an increase in the temperature of the reaction solution, a greater possibility of 
association can occur.  Conversely, when Lysozyme and PBQ in solution are moving 
around at a reduced speed due to a decrease in the temperature of the reaction solution, a 
reduced possibility of association can occur.  To quantify this degree of modification of 
Lysozyme, RIFI values were calculated using Lyz + PBQ (0.050 mM) 37°C as the 
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of Lysozyme when increasing the temperature and a decrease of modification of 
Lysozyme when decreasing the temperature.  Similar to the previous study, incubating 
Lysozyme with PBQ regardless of the temperature of the reaction solution causes a 
modification of Lysozyme.  However, considering conditions at physiological 
temperature (37°C), a decrease in temperature causes less modification of Lysozyme and 
an increase in temperature causes a greater modification of Lysozyme.  Considering all 
reactions performed in this study, Table 2.6 shows no more than a 2% difference in RIFI 
values calculated over the two integration ranges. 
 As seen in Figure 2.12, the absorbance in the 300-410 nm range increases as the 
temperature of the reaction solution increases.  Since quinone absorbs in this range, and 
any free quinone has already been removed through dialysis, the increase in absorbance is 
believed to be result of PBQ covalently bonded to Lysozyme.  To monitor this, Table 2.6 
shows the absorbance at 346 nm of Lysozyme incubated with PBQ at 27°C, 37°C, and 
42°C.  From these results, increasing the temperature of the reaction solution increases 
the absorbance at 346 nm.  Again, any incubation of Lysozyme with PBQ will cause an 
increase in the overall absorbance of Lysozyme due to covalently bonded PBQ 
molecules, however, in this study, comparisons to physiological temperature were made, 
and increases in absorbance were noted as temperature increases. 
 In summary, Lysozyme modification was found to be increasing with respect to 
increasing temperature.  This study shows again that PBQ exhibits its modifying 
capabilities through both induction of protein oligomerization and adduct formation at 
multiple temperatures. 
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2.4 Conclusions 
 
 Lysozyme modifications were observed with all quinone incubations as well as 
when environmental conditions were altered for reactions involving Lysozyme and PBQ.  
Six different studies were performed and each study provided insight on the modification 
of Lysozyme.  Lysozyme modification, through protein oligomerization and adduct 
formation, was found to be increasing with the concentration of PBQ.  Specifically, 
Lysozyme modification appears to be dominated by redox cycling and adduct formation 
within the first 3 h of incubation with PBQ.  As the electron withdrawing capability of 
substituents on PBQ increases, so does modification of Lysozyme through protein 
oligomerization and adduct formation.  Naphthoquinones elicit similar modification to 
Lysozyme with ONQ producing the largest modification.  Considering environmental 
conditions, Lysozyme modification was found to be dependent on varying both the pH 
and temperature of the reaction solution. 
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CHAPTER 3 
STUDIES OF RIBONUCLEASE A MODIFICATIONS  
INDUCED BY 2-HYDROXY-1,4-NAPHTHOQUINONE 
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3.1 Introduction 
 
In previous SDS-PAGE studies performed by Smith & Kim, HNQ was not found 
to produce protein crosslinking of Ribonuclease A [Smith & Kim, 2015].  Instead, HNQ 
was assumed to elicit adduct formation which was too sensitive of a modification to be 
detected by SDS-PAGE.  In the study here, fluorescence and UV-VIS spectroscopy were 
used to aid previous research by investigating the modification of Ribonuclease A by 
HNQ. 
 
3.2 Methodology 
 
All chemicals were purchased from Acros Organics and were of reagent grade.  
The protein of interest, Ribonuclease A (from bovine pancreas), was purchased from 
Fisher and kept frozen for preservation until ready for use.  All water used in this study 
was deionized (DI) water purified by a Millipore system (Milli-Q).  All solutions were 
made in lab and kept sealed or covered until ready for use.  All reactions were performed 
in a similar manner following the devised experimental protocol to keep error at a 
minimum.  Each study was performed over a three-day period consisting of (1) 
preparing and starting the reaction, (2) performing dialysis of the incubated solution, and 
(3) finishing the reaction.  Quartz cuvettes, purchased from Starna Cells, Inc., were re-
used after being thoroughly cleaned with Starna Cells, Inc. cuvette cleaner and allowed 
to dry.  Physiological conditions (pH=7.0, 37°C) were modeled for all reactions except 
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for the studies in which the pH was varied.  At all times, proper laboratory protocol was 
followed and the laboratory was kept in clean and functional condition. 
 
3.2.1 Buffer Solution 
A phosphate buffer (50 mM), comprised of a mixture of monobasic monosodium 
phosphate crystal (NaH2PO4·H2O) and dibasic disodium phosphate anhydrous 
(Na2HPO4), was prepared and used for all reactions in this study.  Most reactions were 
performed at pH=7.0 and 37°C to mimic physiological conditions; however, additional 
reactions were performed at a different pH to study the effect of changing the 
environmental factors.  The phosphate buffer solution was used in every 3 mL reaction 
cuvette as well as in 1 L beakers when performing dialysis.  Solutions of NaH2PO4·H2O 
(50 mM) and Na2HPO4 (50mM) were combined in ratios to produce a solution at a pH 
pre-determined by the Henderson-Hasselbalch equation (Eq. 3.1). 
𝑝𝐻 = 𝑝𝐾𝑎 + 𝑙𝑜𝑔
[𝑏𝑎𝑠𝑒]
[𝑎𝑐𝑖𝑑]
  (Eq. 3.1) 
A phosphate buffer solution was chosen primarily because of the multiple 
dissociation constants of phosphoric acid.  Since the second deprotonation of phosphoric 
acid has a pKa around 7.2, an equilibrium between NaH2PO4·H2O and Na2HPO4 creates 
an effective buffering range around pH=7.0.  Due to the physiological approach of the 
study, the use of phosphates in the buffer solution keeps the study in line with biological 
systems.   
To perform a reaction, 4 L of buffer was made fresh the day before each reaction.  
14.19 g of Na2HPO4 (50mM) was weighed and carefully poured in a 2 L volumetric flask 
followed by dilution to the line with deionized water.  Following the same procedure, 
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13.79 g of NaH2PO4·H2O (50 mM) was weighed and carefully poured in a similar 2 L 
volumetric flask, again diluting to the line with deionized water.  To have enough 
Na2HPO4 (50 mM) for pH=7.0, an additional 0.0500 L of Na2HPO4 (50 mM) was made 
by weighing 3.55 g of Na2HPO4 (50 mM) and following the same dilution and mixing 
protocol mentioned above.  These flasks were subjected to stirring by mechanical means 
for roughly 30 min.  Once fully dissolved, the two solutions of acid and base were 
combined in pre-determined ratios, 1 L at a time, to produce the desired pH of the buffer. 
For example, for a buffer solution at pH=7.0, 557 mL of Na2HPO4 (50 mM) was 
combined with 443 mL of NaH2PO4·H2O (50 mM), adequately mixed, and transferred 
into a 4 L plastic jug.  This process was repeated three additional times to produce 4 L of 
buffer solution. The final pH of solution was checked using a Fisher AB15 Accumet pH 
meter equipped with an AccuTupH probe.  After calibration with stock solutions at 
pH=4.00 and pH=10.01, if the pH of the buffer solution was within ± 0.05 units of the 
desired pH, the solution was acceptable and was stored in the fridge at 4°C until ready for 
use. 
 
3.2.2 Protein Solution 
Ribonuclease A stock solutions were made to provide enough protein for the 
extent of this study.  This involved carefully weighing an imprecise amount of 
Ribonuclease A, 0.1221 g, onto tared weigh-paper and quantitatively transferring into a 
10 mL volumetric flask.  Phosphate buffer (50 mM, pH=7.0) was used to wash any 
residual Ribonuclease A off the weigh-paper into the volumetric flask.  Ribonuclease A, 
in the volumetric flask, was diluted to the line with phosphate buffer (50 mM, pH=7.0) 
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and the flask was capped and sealed with ParaFilm.  To facilitate the protein into 
solution, sonication was performed for 15 min in addition to inversion and shaking the 
volumetric flask by hand.  After sonication, the protein solution was carefully transferred 
to Eppendorf tubes and stored in the freezer until needed.   
The concentration of stock Ribonuclease A was calculated by converting 0.1221 g 
of Ribonuclease A to moles of Ribonuclease A and then dividing by 0.0100 L.  To 
convert grams to moles, 0.1221 g of Ribonuclease A was divided by 13682 g/mol, the 
molecular weight of Ribonuclease A.  This value was then divided by 0.0100 L to 
determine the molarity, or concentration, of the stock Ribonuclease A.  Finally, this 
concentration was multiplied by 1000 to express the concentration in mM, a unit easier to 
manipulate during future calculations.  As result, the concentration of stock Ribonuclease 
A was determined to be 0.8924 mM. 
To perform a reaction, one Eppendorf tube containing the stock Ribonuclease A 
was retrieved from the freezer and allowed to thaw out on ice for 20 min, on the counter 
for 20 min, and finally in the hand for a few minutes.  Once completely thawed, the 
protein solution was vortexed for 1 min to ensure homogeneity before being ready for 
use.   
For all studies involving the modification of Ribonuclease A by HNQ, 
Ribonuclease A was fixed at a concentration of 0.050 mM.  Calculations were performed 
to determine the exact volume of stock Ribonuclease A to add to each reaction cuvette to 
obtain a Ribonuclease A concentration of 0.050 mM.  This was performed using 
Equation 3.2 where M1 is the concentration of stock Ribonuclease A (0.8924 mM), V1 is 
the required aliquot of stock Ribonuclease A to be added to the reaction cuvette, M2 is the 
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desired concentration of RNase A (0.050 mM), and V2 is the desired volume in the 
reaction cuvette (3000 μL).   
𝑀1𝑉1 = 𝑀2𝑉2   (Eq. 3.2) 
As result, 168 μL of stock Ribonuclease A was transferred to a 3 mL reaction 
cuvette containing phosphate buffer (50 mM) to achieve a Ribonuclease A concentration 
of 0.050 mM used for all studies. 
 
3.2.3 Quinone Solution 
Solutions of HNQ were made fresh for every reaction performed.  This involved 
weighing an amount of HNQ on tared weigh-paper (a mass between 0.0100 g and 0.0200 
g) and quantitatively transferring to a 10 mL volumetric flask.  To ensure all protein was 
transferred into the volumetric flask, 10% MeOH/90% phosphate buffer (50 mM) was 
used to wash any residual HNQ off the weigh-paper into the volumetric flask.  HNQ, in 
the volumetric flask, was diluted to the line with 10% MeOH/90% phosphate buffer (50 
mM) and capped and sealed with ParaFilm.  To facilitate HNQ into solution, sonication 
was performed for 10 min in addition to inversion and shaking the volumetric flask by 
hand.  Halfway through the sonication procedure, the volumetric flask was removed, 
inverted to mix the solution, and then placed back into the sonicator.  After sonication, 
the HNQ solution was transferred into a small holding beaker, covered with foil, and was 
ready for use. 
It is important to note that only the volumetric flask containing the HNQ solution 
contained 10% MeOH.  Once the HNQ, in solution, was transferred from the small 
holding beaker to the reaction cuvette, phosphate buffer (50 mM) was used to bring the 
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reaction cuvette up to volume.  Over all studies performed, the relative concentration of 
10% MeOH in the reaction cuvette was minimal and not enough to influence the reaction 
being performed. 
During the sonication procedure, the concentration of HNQ prepared in solution 
was calculated by converting the mass of HNQ to moles of HNQ and then dividing by 
0.0100 L.  To convert grams of HNQ to moles of HNQ, the mass of HNQ was divided by 
the molar mass of HNQ.  This value was then divided by 0.0100 L to determine the 
molarity, or concentration, of the quinone in solution.  Finally, this concentration was 
multiplied by 1000 to express the concentration in mM, a unit easier to manipulate during 
future calculations. 
In addition, further calculations were performed during the sonication process to 
determine the exact volume of HNQ solution to add to the reaction cuvette containing 
RNase A (0.050 mM) and phosphate buffer (50 mM) to achieve the desired concentration 
of HNQ in the reaction cuvette.  This was calculated using Equation 3.3 where, in this 
case, M1 is the actual concentration of the HNQ solution prepared, V1 is the required 
aliquot of HNQ solution to be added to the reaction cuvette, M2 is the desired 
concentration of HNQ, and V2 is the desired volume in the reaction cuvette (3000 μL).   
𝑀1𝑉1 = 𝑀2𝑉2   (Eq. 3.3) 
Since several concentrations of HNQ were used across all studies, and the amount 
of HNQ weighed out each time was not the same, the amount of HNQ solution added to 
the reaction cuvette varied reaction to reaction. 
For the study involving different concentrations of HNQ, aliquot volumes were 
calculated for desired concentrations of 0.050 mM, 0.10 mM, 0.25 mM, 0.50 mM, and 
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1.5 mM.  For the study involving HNQ incubated with Ribonuclease A at different pH, 
aliquot volumes were calculated for a fixed concentration of 0.10 mM.  This 
concentration was determined best to work with when comparing different variables of 
reactions because it provided a concentration high enough to interact well with 
Ribonuclease A. 
Once the calculated volume of HNQ solution was added to the reaction cuvette 
containing RNase A (0.050 mM) and phosphate buffer (50 mM), the reaction began, the 
cuvette was placed into the fluorimeter for scanning, and the reaction time was kept on a 
scientific timer. 
 
3.2.4 Fluorescence Spectroscopy & Anisotropy Measurements 
Fluorescence spectroscopy was performed using a Horiba Jobin Yvon Fluorolog 
spectrophotometer equipped with a Xenon lamp.  The excitation wavelength was fixed at 
280 nm with a 2 nm slit width to accommodate the tyrosine residues in Ribonuclease A.  
The resulting emission was recorded every 1 nm with a slit width of 2 nm over the range 
of 290-600 nm.  To draw correlations between all studies, each spectrum was normalized 
from 500-550 nm where little emission was recorded.  Microsoft Excel was used to 
analyze the data and to produce graphs to visualize the fluorescence spectra. 
All reactions were performed in a quartz cuvette in phosphate buffer (50 mM).  
The cuvette was equipped with a stir bar to ensure proper mixing and to minimize 
sedimentation of Ribonuclease A.  The stirring motion was set to the 3rd level of power as 
indicated on the fluorimeter.  Emission scanning lasted around 10 min and varied 
occasionally in duration due to mechanical motion inside of the fluorimeter.  Initial 
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scanning, or reaction scanning, of Ribonuclease A occurred over 24 h with scans 
occurring every hour for that duration.  Post-modified Ribonuclease A was returned to a 
quartz cuvette after a 24 h dialysis and scanned an additional four times.  This resulting 
data was recorded, averaged, and analyzed in Microsoft Excel to produce the graphs 
presented in this study.  A control was produced by subjecting RNase A (0.050 mM) in 
phosphate buffer (50 mM) to the same procedure as every reaction performed. 
The software to operate the fluorimeter was FluorEssence by Horiba Jobin Yvon.  
This software was capable of automating fluorescence and anisotropy scans which were 
utilized to accomplish the 24 h scans of each study.  The first and second scans were 
always started manually with each consecutive scan being automatically started by the 
programming.  Since each emission scan lasted around 10 min (600 s), the instrument 
was programmed to scan the reaction every 2997 s for 24 h to accomplish 24 h of 
scanning each hour.  Due to the mechanical motion of parts inside of the fluorimeter, an 
additional 3 s was added to accommodate the automated re-calibration of the instrument 
after each scan.  Due to fluctuations in voltage supplied to the instrument, the timing of 
the scans slightly varied for each reaction and occasionally needed to be reset during the 
reaction. 
The process of performing fluorescence measurements was performed in a similar 
manner for every reaction by following a pre-determined protocol.  To begin, the 
fluorimeter was turned on by first switching on the water bath, the fan, the lamp, and then 
the software PC.  The lamp was allowed to warm up for 1 h before any measurements 
took place.  The instrument was initialized by selecting to perform a spectra study, 
specifically an emission study, and then by executing a trial scan (C1-Trial) with the 
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cuvette containing only Ribonuclease A and phosphate buffer (50 mM).  Once the 
initialization was complete and the trial scan was acceptable, the software was used to 
program the instrument for fluorescence measurements.  A scientific timer was obtained 
and started as soon as the aliquot of HNQ was administered to the reaction cuvette 
containing Ribonuclease A and phosphate buffer.  After this, the reaction cuvette was 
capped, the sides wiped with Kimwipes, inverted 3 times, and placed in the fluorimeter 
for scanning.  Once securely positioned inside the fluorimeter, the fluorescence scanning 
was started and the time on the scientific timer was recorded.  This time was the delay 
between the actual start of the reaction of Ribonuclease A with HNQ and the initial 
emission scanning of the reaction.  In addition, the time of day was recorded to be able to 
monitor the start and stop of each consecutive measurement every hour. 
Post-modified Ribonuclease A fluorescence measurements were performed using 
a different programmed scanning procedure as initial scanning.  In these scans, modified 
Ribonuclease A was scanned four times in the time frame of 1 h at 37°C.  Once these 
scans were complete, the cuvette was removed from the fluorimeter and the instrument 
was shut down in the reverse order in was turned on.  This concluded the use of 
fluorescence spectroscopy to measure the modification of Ribonuclease A induced by 
HNQ. 
In addition to fluorescence measurements, anisotropy measurements were 
performed as well during initial and post-modified scanning of Ribonuclease A.  
Appendix B shows anisotropy measurements for each study performed using 
Ribonuclease A.  A general trend can be seen in each graph indicating the correlation 
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between increasing modification of Ribonuclease A and increasing anisotropy values of 
Ribonuclease A. 
Overall, the studies performed with fluorescence spectroscopy helped aid 
previous research in positively confirming modification of Ribonuclease A by HNQ. 
 
3.2.5 UV-VIS Spectroscopy 
UV-VIS spectroscopy was performed using a double-beam UV-1800 Shimadzu 
UV Spectrophotometer.  The instrument was allowed to warm up for 20 min before any 
measurements took place.  Excitation was achieved using a D2/W lamp with the resulting 
spectra recorded at 1 nm sampling intervals over the range of 200-700 nm with the scan 
speed set to fast.  The slit width was 1.0 nm and the D2/W light change was set at 340.8 
nm.  The instrument was auto-zeroed and baselined prior to every scan to account for 
background noise.  Microsoft Excel was used to analyze the data recorded and to produce 
the graphs presented in this study.   
Immediately after fluorescence scanning was complete, the cuvette was 
transferred into the UV-VIS spectrophotometer for analysis.  Absorbance of the analyte 
was recorded and immediately processed on screen using the software UV Probe 2.33.  A 
reference cell containing phosphate buffer (50 mM, pH=7.0) was prepared at the 
beginning of the study and was used for every reaction throughout the study.  This 
insured the absorbance calculated by the instrument was solely from Ribonuclease A and 
any bound or unbound HNQ.  Pre-dialysis Ribonuclease A exhibited larger absorbance 
than post-dialysis Ribonuclease A due to unbound HNQ in solution absorbing light.  
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Removal of unbound HNQ by dialysis reduced the absorbance of the analyte and 
produced a more accurate representation of modified Ribonuclease A. 
 All UV-VIS measurements were performed in the same manner and used to 
measure the amount of modification (by adduct formation) of Ribonuclease A.  Overall, 
the studies performed with UV-VIS spectroscopy helped aid previous research in 
positively confirming modification of Ribonuclease A by HNQ. 
 
3.2.6 Dialysis 
To accurately measure the modification of Ribonuclease A induced by HNQ, 
dialysis was performed to remove unbound HNQ that was not covalently bonded to 
Ribonuclease A.  Spectroscopically measuring Ribonuclease A with bound HNQ alone 
gives clear understanding of the modification of Ribonuclease A induced by HNQ.   
Dialysis was performed using a 5 mL Float-A-Lyzer purchased from Spectrum 
Laboratories.  The membrane, with a molecular cutoff of 3.5 kDa, allowed unbound 
HNQ to freely exit through the membrane.  Ribonuclease A, with a molecular mass of 
13.6 kDa, or modified Ribonuclease A, with a slightly higher molecular mass, remained 
inside of the dialysis membrane along with any HNQ bound to the protein via ionic 
bonding, covalent bonding, or H-bonding.  Before use, each dialysis membrane was 
thoroughly soaked, washed, and rinsed with DI water and then temporarily held in 
phosphate buffer solution (50 mM) kept at 4°C.  Before the reaction solution could be 
transferred into the dialysis membrane, the membrane was emptied of phosphate buffer 
solution to insure proper concentration of the protein and HNQ in solution.  Once the 
reaction solution was carefully transferred from the reaction cuvette to the dialysis 
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membrane by a disposable pipette, the dialysis membrane was placed in 900 mL of 
phosphate buffer solution and kept at 4°C for 24 h.  Facilitation of unbound HNQ out of 
the dialysis membrane was accelerated by the concentration gradient between the 
phosphate buffer solution and the reaction solution as well as by stirring using a stir bar.  
Since the concentration of quinone outside of the dialysis membrane was less than the 
concentration of quinone inside of the dialysis membrane, simple diffusion occurred and 
the unbound HNQ exited the dialysis membrane.  This was further accelerated by 
changing out the phosphate buffer solution three times, typically every 2.5 h.  By doing 
this, the concentration gradient became smaller each time and diffusion continued to take 
place.  After three buffer changes, and considering the volume of reaction solution to 
phosphate buffer solution, it is safe to assume all unbound HNQ had been washed from 
the reaction solution. 
After 24 h of dialysis, the contents in the dialysis membrane were returned to a 
clean reaction cuvette and placed in the fluorimeter for post-dialysis fluorescence 
scanning.  By removal of unbound quinone in solution, the modification of Ribonuclease 
A by bound HNQ was measured and quantified by fluorescence and UV-VIS 
spectroscopy. 
 
3.3 Results and Discussion 
 
The results of several reactions involving Ribonuclease A are presented below.  Two 
official studies were conducted: (1) a study with HNQ at various concentrations, and (2) 
a study focused on the pH dependence of HNQ.  Fluorescence and UV-VIS graphs are 
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included for each study.  The graphs depict the fluorescence intensity and absorbance of 
post-dialysis Ribonuclease A.  Post-dialysis Ribonuclease A (i.e. modified Ribonuclease 
A) refers to Ribonuclease A which has completed a 24 h dialysis and contains only 
Ribonuclease A and any bound quinone to the protein. 
 Normalized integrated fluorescence intensity (NIFI) values were obtained by 
selecting a range of wavelengths and calculating the area under the curve of each 
fluorescence spectrum.  Two separate wavelength ranges were chosen for all calculations 
of NIFI.  The integration range of 290-400 nm spans the entire emission area while the 
integration range 300-330 nm narrows in on the maximum fluorescence intensity for each 
reaction.  This was done to account for minor blips in the fluorescence spectra and to 
measure uniformity when comparing results.  Two reference NIFIs were used, RNase A 
(0.050 mM) for the study with HNQ at various concentrations and RNase A + HNQ (0.10 
mM) pH=7.0 for the study focused on the pH dependence of HNQ.  To quantify the 
modification of Ribonuclease A from different studies, a reduced integrated fluorescence 
intensity (RIFI) value was calculated by dividing the NIFI of the study in question by the 
reference NIFI, converting to a percentage, and then subtracting from 100%.  Reference 
NIFIs have RIFIs of 0% since 100%-100% = 0% and negative RIFIs represent an 
increase in fluorescence intensity since the corresponding NIFI is greater than the 
reference NIFI. 
 Through observation of a reduction of fluorescence intensity and an increase in 
absorbance, modification of Ribonuclease A was confirmed from the results of these 
studies. 
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3.3.1 Ribonuclease A Modifications Induced by HNQ at Various Concentrations 
In this study, RNase A (0.050 mM) was treated with HNQ (0.050, 0.10, 0.25, 
0.50, or 1.5 mM) and allowed to react while being monitored using fluorescence for 24 h.  
Following the 24 h incubation, dialysis was performed for an additional 24 h followed by 
a final spectroscopic measurement of modified Ribonuclease A.  All reactions were 
performed in a phosphate buffer (50 mM) at 37°C and pH=7.0 to mimic physiological 
conditions. 
Table 3.1 lists RIFI values calculated over 290-400 nm and 300-330 nm in 
addition to absorbance values for each reaction performed in this study.  Figure 3.1 shows 
the fluorescence intensity of Ribonuclease A and Ribonuclease A modified by HNQ 
(0.050, 0.10, 0.25, 0.50, or 1.5 mM) for 24 h at 37°C.  All spectra were normalized in the 
500-550 nm range where little emission is present to ensure proper comparison.  Figure 
3.2 shows the absorbance of Ribonuclease A and Ribonuclease A modified by HNQ 
(0.050, 0.10, 0.25, 0.50, or 1.5 mM) for 24 h at 37°C.   
As seen in Figure 3.1, the fluorescence intensity decreases as the concentration of 
HNQ increases in the reaction solution.  From the results of previous studies, it was 
found exposure of Ribonuclease A to HNQ does not elicit protein oligomerization over 
time.  However, from the results of this study, a decrease in fluorescence intensity was 
observed.  This reduction of fluorescence intensity is believed to be result of other means 
of protein modification, such as adduct formation. 
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Table 3.1 RIFI of RNase A (0.050 mM) and RNase A (0.050 mM) modified by 
HNQ (0.050, 0.10, 0.25, 0.50, or 1.5 mM) for 24 h at 37°C.  Absorbance 
at 346 nm of RNase A (0.050 mM) and RNase A (0.050 mM) modified by 
HNQ (0.050, 0.10, 0.25, 0.50, or 1.5 mM) for 24 h at 37°C. 
Reaction RIFIa (%) RIFIb (%) A346 (a.u.) 
RNase A (0.050 mM) 0 0 -0.002 
RNase A + HNQ (0.050 mM) 11 11 0.029 
RNase A + HNQ (0.10 mM) 32 31 0.057 
RNase A + HNQ (0.25 mM) 47 46 0.088 
RNase A + HNQ (0.50 mM) 90 91 0.283 
RNase A + HNQ (1.5 mM) 97 98 1.035 
a integration between 290-400 nm 
b integration between 300-330 nm 
 
 
 
Figure 3.1 Fluorescence spectra of RNase A (0.050 mM) and RNase A (0.050 mM) 
modified by HNQ (0.050, 0.10, 0.25, 0.50, or 1.5 mM) for 24 h at 37°C. 
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Figure 3.2 UV-VIS spectra of RNase A (0.050 mM) and RNase A (0.050 mM) 
modified by HNQ (0.050, 0.10, 0.25, 0.50, or 1.5 mM) for 24 h at 37°C. 
 
To quantify the degree of modification of Ribonuclease A, RIFI values were 
calculated using RNase A (0.050 mM) as the reference NIFI.  As seen in Table 3.1, the 
RIFI increases as the concentration of HNQ in the reaction solution increases.  This is 
interpreted as an increase in the modification of Ribonuclease A upon exposure to 
increasing concentration of HNQ.  Considering all reactions performed in this study, 
Table 3.1 shows no more than a 1% difference in RIFI values calculated over the two 
integration ranges. 
 As seen in Figure 3.2, the absorbance in the 320-550 nm range increases as the 
concentration of HNQ increases in the reaction solution.  Since HNQ absorbs in this 
range, and any free HNQ has already been removed through dialysis, the increase in 
absorbance is believed to be result of HNQ covalently bonded to Ribonuclease A.  To 
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monitor this, Table 3.1 shows the absorbance at 346 nm of Ribonuclease A and modified 
Ribonuclease A.  From these results, increasing the concentration of HNQ increases the 
overall absorbance of modified Ribonuclease A.  This is interpreted as an increase in the 
modification of Ribonuclease A upon increasing concentration of HNQ. 
 In summary, Ribonuclease A modification was found to be increasing with the 
concentration of HNQ.  In addition to the SDS-PAGE data presented in Chapter 1 [Smith 
& Kim, 2015], and similar to what was observed during previous studies with 
Ribonuclease A, this study shows HNQ exhibits its modifying capabilities solely through 
adduct formation. 
 
3.3.2 Ribonuclease A Modifications Induced by HNQ at Various pH 
In this study, RNase A (0.050 mM) was treated with HNQ (0.010 mM) at pH=6.0, 
pH=7.0, and pH=8.0 and allowed to react while being monitored using fluorescence for 
24 h.  Following the 24 h incubation, dialysis was performed for an additional 24 h 
followed by a final spectroscopic measurement of modified Ribonuclease A.  All 
reactions were performed in a phosphate buffer (50 mM) at 37°C.   
Table 3.2 lists RIFI values calculated over 290-400 nm and 300-330 nm in 
addition to absorbance values for each reaction performed in this study.  Figure 3.3 shows 
the fluorescence intensity of Ribonuclease A and Ribonuclease A modified by HNQ 
(0.10 mM) at pH=6.0, pH=7.0, and pH=8.0 for 24 h at 37°C.  All spectra were 
normalized in the 500-550 nm range where little emission is present to ensure proper 
comparison.  Figure 3.4 shows the absorbance of Ribonuclease A and Ribonuclease A 
modified by HNQ (0.10 mM) at pH=6.0, pH=7.0, and pH=8.0 for 24 h at 37°C. 
 80 
 
Table 3.2 RIFI of RNase A (0.050 mM) modified by HNQ (0.10 mM) at pH=6.0, 
pH=7.0, and pH=8.0 for 24 h at 37°C.  Absorbance at 346 nm of RNase A 
(0.050 mM) modified by HNQ (0.10 mM) at pH=6.0, pH=7.0, and pH=8.0 
for 24 h at 37°C. 
Reaction RIFIa (%) RIFIb (%) A346 (a.u.) 
RNase A + HNQ (0.10 mM) pH=6.0 -1 -2 0.048 
RNase A + HNQ (0.10 mM) pH=7.0 0 0 0.057 
RNase A + HNQ (0.10 mM) pH=8.0 52 53 0.109 
a integration between 290-400 nm 
b integration between 300-330 nm 
 
As seen in Figure 3.3, the fluorescence intensity decreases as the pH of the 
reaction solution increases from 7.0 to 8.0 and remains much the same as the pH of the 
reaction solution decreases from 7.0 to 6.0.  This is believed to be due to increasing and 
decreasing the nucleophilic character of the protein and therefore increasing and 
decreasing the likelihood of association of Ribonuclease A and HNQ.  In addition, since 
protein oligomerization is not induced by HNQ, or influenced by pH changes, increasing 
the pH of the reaction solution encourages other means of protein modification to occur, 
such as adduct formation.  To quantify this degree of modification of Ribonuclease A, 
RIFI values were calculated using RNase A + HNQ (0.10 mM) pH=7.0 as the reference 
NIFI.  As seen in Table 3.2, the RIFI increases only as the pH of the reaction solution 
increases from 7.0 to 8.0 and is found to have little change when the pH of the reaction 
solution is decreased from 7.0 to 6.0.  This is interpreted as an increase of modification of 
Ribonuclease A only upon increasing the pH of the reaction solution.   
 81 
 
 
Figure 3.3 Fluorescence spectra of RNase A (0.050 mM) modified by HNQ (0.10 
mM) at pH=6.0, pH=7.0, and pH=8.0 for 24 h at 37°C. 
 
Obviously, incubating Ribonuclease A with HNQ regardless of the pH causes a 
modification of Ribonuclease A.  However, considering conditions at physiological pH, 
an increase in pH causes greater modification of Ribonuclease A and a decrease in pH 
causes little to no change in the modification of Ribonuclease A.  Considering all 
reactions performed in this study, Table 3.2 shows no more than a 1% difference in RIFI 
values calculated over the two integration ranges. 
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Figure 3.4 UV-VIS spectra of RNase A (0.050 mM) modified by HNQ (0.10 mM) at 
pH=6.0, pH=7.0, and pH=8.0 for 24 h at 37°C. 
 
As seen in Figure 3.4, the absorbance in the 320-550 nm range increases as the 
pH of the reaction solution increases from 7.0 to 8.0 and decreases slightly as the pH of 
the reaction solution decreases from 7.0 to 6.0.  Since HNQ absorbs in this range, and any 
free HNQ has already been removed through dialysis, the increase and decrease in 
absorbance is believed to be result of HNQ covalently bonded to Ribonuclease A.  To 
monitor this, Table 3.2 shows the absorbance at 346 nm of Ribonuclease A incubated 
with HNQ at pH=6.0, pH=7.0, and pH=8.0.  From these results, increasing the pH of the 
reaction solution from 7.0 to 8.0 increases the absorbance and decreasing the pH of the 
reaction solution from 7.0 to 6.0 decreases the absorbance.  Again, any incubation of 
Ribonuclease A with HNQ will cause an increase in the overall absorbance of 
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Ribonuclease A, however, in this study, comparisons to physiological pH were made, and 
increases and decreases in absorbance were noted as result. 
 Considering the results of this study, several assumptions can be made.  For 
example, increasing the pH of solution gives rise to increasing deprotonation of 
Ribonuclease A which results in greater attractive forces between HNQ and Ribonuclease 
A.  In addition, because the pKa of the hydrogen on hydroxyl group of HNQ is 4.3, HNQ 
assumes a negative partial charge in all incubations at pH=6.0, pH=7.0, and pH=8.0 
[Scifinder].  This would result in greater association of HNQ to positively charged amino 
acid residues of Ribonuclease A upon increasing the pH and less association of HNQ to 
positively charged amino acid residues of Ribonuclease A upon decreasing the pH.  In 
contrast, decreasing the pH of solution gives rise to increasing protonation of HNQ and 
Ribonuclease A which would result in greater repulsive forces and lessen the interaction 
between the two.  Although Figure 3.3 does not show a large increase in fluorescence 
spectroscopy of the reaction RNase A + HNQ (0.10 mM) pH=6.0, Figure 3.4 does show 
slight differences between the reactions performed at pH=6.0 and pH=7.0.  Because UV-
VIS spectroscopy is believed to detect changes due to adduct formation, the reaction 
performed at pH=6.0 shows supporting results of less modification due to greater 
amounts of HNQ and Ribonuclease A repelling one another as result of protonation 
caused by the lower pH. 
 In summary, Ribonuclease A modification was found to be increasing with 
respect to increasing the pH of the reaction solution from 7.0 to 8.0 and unchanged when 
decreasing the pH of the reaction solution from 7.0 to 6.0.  In addition to SDS-PAGE 
data presented in Chapter 1 [Smith & Kim, 2015], this study shows HNQ exhibits its 
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modifying capabilities solely through adduct formation and is largely unaffected by 
decreases in pH. 
 
3.4 Conclusions 
 
 Ribonuclease A modifications were observed with HNQ incubations as well as 
when environmental conditions were altered.  Ribonuclease A modification, through 
adduct formation, was found to be increasing with the concentration of HNQ.  In 
addition, Ribonuclease A modification was found to be increasing with respect to 
increasing the pH of the reaction solution from 7.0 to 8.0 and unchanged when decreasing 
the pH of the reaction solution from 7.0 to 6.0.  In support of previous studies [Smith & 
Kim, 2015], HNQ was observed to exhibit its protein modifying capabilities solely 
through adduct formation and does not produce protein oligomerization. 
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APPENDIX A 
 
Anisotropy measures the non-sphericity of a molecule by recording the amount of 
emitted light that passes through different polarized planes.  In these studies, larger 
values of anisotropy correspond to Lysozyme that has been modified resulting in 
polymerization or an overall non-spherical shape, while smaller values of anisotropy 
correspond to Lysozyme that has been modified resulting in an increased spherical shape.   
Anisotropy values of post-dialysis Lysozyme recorded from 300-450 nm 
corresponding to each of the six different studies performed are presented in the 
following pages.  These values were averaged and general trends in anisotropy were 
observed as result. 
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Figure A.1 Anisotropy values recorded from 300-450 nm with an average anisotropy 
value of Lyz (0.010 mM) and Lyz (0.010 mM) modified by PBQ (0.010, 
0.050, 0.10, or 0.30 mM) for 24 h at 37°C. 
 
A general trend of increasing anisotropy with increasing concentration of PBQ is 
observed.  These results suggest PBQ alters the structure of Lysozyme by 
oligomerization and adduct formation resulting in an overall non-spherical shape of the 
protein. 
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Figure A.2 Anisotropy values recorded from 300-450 nm with an average anisotropy 
value of Lyz (0.010 mM) and Lyz (0.010 mM) modified by PBQ (0.050 
mM) for 0 h, 1 h, 2 h, 3 h, and 24 h at pH=7.0 and 37°C. 
 
These results suggest the overall sphericity of Lysozyme increases upon initial 
exposure to PBQ and becomes non-spherical after several hours of incubation. 
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Figure A.3 Anisotropy values recorded from 300-450 nm with an average anisotropy 
value of Lyz (0.010 mM) and Lyz (0.010 mM) modified by MBQ (0.050 
mM), PBQ (0.050 mM), PhBQ (0.050 mM), CBQ (0.050 mM), and 
TCBQ (0.050 mM) for 24 h at 37°C. 
 
A general trend of increasing anisotropy with increasing electron withdrawing 
capability of each substituted quinone is observed.  These results suggest substituted 
quinones alter the structure of Lysozyme by oligomerization and adduct formation 
resulting in an overall non-spherical shape of the protein.  Consistent with Figures 2.5 
and 2.6, PhBQ modifies Lysozyme in a way that increases the sphericity of the protein. 
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Figure A.4 Anisotropy values recorded from 300-450 nm with an average anisotropy 
value of Lyz (0.010 mM) and Lyz (0.010 mM) modified by HNQ (0.050 
mM), PNQ (0.050 mM), and ONQ (0.050 mM) for 24 h at 37°C. 
 
The results of these studies indicate naphthoquinones modify Lysozyme resulting 
in an increased spherical shape of the protein.  Specifically, with support of Figures 2.7 
and 2.8, ONQ elicits the largest degree of modification and is shown to modify 
Lysozyme in a way that increases the sphericity of the protein. 
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Figure A.5 Anisotropy values recorded from 300-450 nm with an average anisotropy 
value of Lyz (0.010 mM) modified by PBQ (0.050 mM) at pH=6.0, 
pH=7.0, and pH=8.0 for 24 h at 37°C. 
 
A general trend of increasing anisotropy with increasing pH of reaction solution is 
observed.  These results suggest increasing the pH of the reaction solution influences the 
modification of PBQ resulting in an overall non-spherical shape of the protein.  In 
contrast, decreasing the pH of the reaction solution influences the modification of PBQ 
resulting in an increased spherical shape of the protein. 
  
0.00
0.04
0.08
0.12
0.16
300 320 340 360 380 400 420 440 460
A
n
is
o
tr
o
p
y
Wavelength (nm)
Lyz + PBQ (0.050 mM) pH=6.0
Lyz + PBQ (0.050 mM) pH=7.0
Lyz + PBQ (0.050 mM) pH=8.0
 95 
 
Figure A.6 Anisotropy values recorded from 300-450 nm with an average anisotropy 
value of Lyz (0.010 mM) modified by PBQ (0.050 mM) at 27°C, 37°C, 
and 42°C for 24 h at pH=7.0. 
 
A general trend of increasing anisotropy with increasing temperature of reaction 
solution is observed.  These results suggest increasing the temperature of the reaction 
solution influences the modification of PBQ resulting in an overall non-spherical shape of 
the protein.  In contrast, decreasing the temperature of the reaction solution influences the 
modification of PBQ resulting in an increased spherical shape of the protein. 
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APPENDIX B 
 
Anisotropy measures the non-sphericity of a molecule by recording the amount of 
emitted light that passes through different polarized planes.  In these studies, larger 
values of anisotropy correspond to Ribonuclease A that has been modified resulting in an 
overall non-spherical shape, while smaller values of anisotropy correspond to 
Ribonuclease A that has been modified resulting in an increased spherical shape.   
Anisotropy values of post-dialysis Ribonuclease A recorded from 300-450 nm 
corresponding to the different studies performed are presented in the following pages.  
These values were averaged and general trends in anisotropy were observed as result. 
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Figure B.1 Anisotropy values recorded from 300-450 nm with an average anisotropy 
value of RNase A (0.050 mM) and RNase A (0.050 mM) modified by 
HNQ (0.050, 0.10, 0.25, 0.50, or 1.5 mM) for 24 h at 37°C. 
 
The results of these studies display no clear trend of increasing or decreasing 
anisotropy with increasing concentration of HNQ.  This suggests HNQ does not modify 
Ribonuclease A in a consistent manner in regard to HNQ concentration. 
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Figure B.2 Anisotropy values recorded from 300-450 nm with an average anisotropy 
value of RNase A (0.050 mM) modified by HNQ (0.10 mM) at pH=6.0, 
pH=7.0, and pH=8.0 for 24 h at 37°C. 
 
The results of these studies display no clear trend of increasing or decreasing 
anisotropy with changes in pH.  Similar to the studies performed with Lysozyme, 
increasing the pH of the reaction solution causes an overall increased non-spherical shape 
of Ribonuclease A.  However, regarding decreases in the pH of the reaction solution, 
these results do not follow a similar trend as seen in Figure A.5.  
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APPENDIX C 
 
 Pre-dialysis and post-dialysis fluorescence scans of Lysozyme (incubated with 
PBQ) and Ribonuclease A (incubated with HNQ) from 290-600 nm are presented below.  
These scans are non-normalized and reflect the changes in fluorescence intensity over the 
initial 24 h incubation with quinone.  The post-dialysis fluorescence scans are represented 
by the dark blue line denoted “AD”. 
 
 
 
Figure C.1 Pre-dialysis and post-dialysis fluorescence scans of Lyz + PBQ (0.050 
mM) for 24 h at 37°C. 
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Figure C.2 Pre-dialysis and post-dialysis fluorescence scans of RNase A + HNQ (0.10 
mM) for 24 h at 37°C.  (The apparent increase of fluorescence intensity of 
post-dialysis RNase A is representative of initial fluorescence quenching 
by the concentrated HNQ solution.) 
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